0000731766-15-000002.txt : 20150121 0000731766-15-000002.hdr.sgml : 20150121 20150121060415 ACCESSION NUMBER: 0000731766-15-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20150121 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150121 DATE AS OF CHANGE: 20150121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 411321939 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 15537395 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 8-K 1 a2014q4er8-k.htm 8-K 2014 Q4 ER 8-K


 
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 21, 2015
—————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
Minnesota
 
1-10864
 
41-1321939
(State or other jurisdiction of incorporation)

 
(Commission File Number)

 
(I.R.S. Employer Identification No.)

UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota
55343
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (952) 936-1300
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 





Item 2.02.    Results of Operations and Financial Condition.
On January 21, 2015, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2014 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.     Financial Statements and Exhibits.
Exhibit
Description
 
 
 
99.1
Press Release dated January 21, 2015




Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 21, 2015                 
 
 
 
UNITEDHEALTH GROUP INCORPORATED
 
 
 
By:
/s/ Richard J. Mattera
 
 
 
 
Richard J. Mattera
 
 
 
 
Assistant Secretary




EXHIBIT INDEX

Exhibit
Description
 
 
 
99.1
Press Release dated January 21, 2015

        

EX-99.1 2 q4exhibit991.htm EXHIBIT Q4 Exhibit 99.1



N E W S R E L E A S E


Investors:
Brett Manderfeld
John Penshorn
Media:
Don Nathan
Tyler Mason
 
Vice President
Senior Vice President
 
Senior Vice President
Vice President
 
952-936-7216
952-936-7214
 
952-936-1885
424-333-6122

(For Immediate Release)

UNITEDHEALTH GROUP REPORTS 2014 RESULTS,
HIGHLIGHTED BY STRENGTH IN GROWTH MARKETS
Revenues of $130.5 Billion Grew 7% Year-Over-Year
Operating Earnings of $10.3 Billion Grew 7% Year-Over-Year
Cash Flows from Operations Grew 15% Year-Over-Year and Exceeded $8 Billion
Full Year Net Earnings Grew to $5.70 Per Share

NEW YORK, N.Y. (January 21, 2015) - UnitedHealth Group (NYSE: UNH) today reported fourth quarter and full year 2014 results, highlighted by Optum’s exceptional revenue growth, margin expansion and earnings advances and broad-based strength in UnitedHealthcare’s public and senior sector benefits business.

“We enter 2015 with a positive outlook and rising business momentum. Steady innovation and year by year advances in the quality, breadth and value of our services to employers, government sponsors, consumers and care providers are creating opportunities for revenue and earnings growth in traditional and new markets,” said Stephen J. Hemsley, chief executive officer of UnitedHealth Group.

The Company estimates 2015 revenues in a range of $140.5 billion to $141.5 billion and projects rising net earnings per share growth in 2015, to a range of $6.00 to $6.25 per share, and strong cash flows from operations in a range of $8.0 billion to $8.4 billion.


Page 1 of 8






Quarterly And Annual Financial Performance
 
 
 
 
Three Months Ended
 
Year Ended
 
December 31,
December 31,
September 30,
 
December 31,
December 31,
 
2014
2013
2014
 
2014
2013
Revenues
$33.4 billion
$31.1 billion
$32.8 billion
 
          $130.5 billion
      $122.5 billion
Earnings From Operations
$2.8 billion
$2.5 billion
$2.9 billion
 
          $10.3 billion
        $9.6 billion
Net Margin
4.5%
4.6%
4.9%
 
4.3%
4.6%

UnitedHealth Group’s full year 2014 revenues of $130.5 billion grew $8 billion or 7 percent year-over-year. UnitedHealthcare growth was led by strength in the public and senior sector, which grew organically to serve more than 1.3 million additional people. Optum’s year-over-year revenue growth rates of 25 percent for the full year and 23 percent in the fourth quarter reflect the market’s growing response to Optum’s distinctive capabilities.
Full year 2014 earnings from operations were $10.3 billion and net earnings were $5.6 billion, or $5.70 per share. The ACA negatively impacted full year net earnings by $1 billion or approximately $1.00 per share. Fourth quarter earnings from operations were $2.8 billion and net earnings were $1.5 billion, or $1.55 per share, as the earnings per share growth rate rose to 10 percent year-over-year in the fourth quarter.
The 2014 consolidated medical care ratio decreased 60 basis points year-over-year to 80.9 percent, reflecting the premium impact of ACA fees, partially offset by an increased mix of public and senior sector business. The fourth quarter medical care ratio of 79.8 percent decreased 140 basis points year-over-year, due to the impact of ACA fees and improved premium yields, partially offset by business mix.
Favorable reserve development was $100 million in the fourth quarter, including $40 million related to the prior year’s medical services, compared to a total of $170 million for the fourth quarter of 2013, including $100 million related to the previous year’s services. Overall medical cost trends remained well controlled, with decreased inpatient hospital usage per person in 2014.
Meaningful improvements in productivity and operating efficiency in 2014 were more than offset by 120 basis points of ACA fees and taxes and the growing mix of health care services business, as the operating cost ratio increased 80 basis points to 16.6 percent. The seasonally higher fourth quarter operating cost ratio of 17.5 percent increased 130 basis points year-over-year due to ACA costs and health care services business growth.
The full year 2014 tax rate of 41.8 percent increased 540 basis points year-over-year due to ACA taxes.


Page 2 of 8



UnitedHealth Group Results - Continued

Cash flows from operations grew 15 percent year-over-year to $8.1 billion, exceeding 1.4x net earnings for the year. Fourth quarter cash flows from operations grew to $2.4 billion, or 1.6x net earnings.
Fourth quarter 2014 days sales outstanding in accounts receivable of 12 days increased 3 days year-over-year, reflecting the growing revenue contribution from state and federal customers and health care services business. Fourth quarter 2014 days claims payable of 47 days were stable year-over-year, and within the expected range of 47 to 50 days.
The Company’s balance sheet remained strong, with nearly $1 billion of cash available for corporate use and a debt to total capital ratio of 35 percent at December 31, 2014. Return on equity again exceeded 17 percent in 2014.
UnitedHealth Group repurchased $4 billion in stock in 2014 at an average price of approximately $82.60 per share, and paid $1.4 billion in shareholder dividends, up 29 percent year-over-year. The dividend was increased by 34 percent in June 2014 to an annual rate of $1.50 per share.



 






Page 3 of 8





UnitedHealthcare provides health care benefits, serving individuals and employers ranging from sole proprietorships to large, multi-site and national and international organizations; delivers health and well-being benefits to Medicare beneficiaries and retirees; manages health care benefit programs on behalf of state Medicaid and community programs; and serves the nation’s active and retired military and their families through the TRICARE program.

Quarterly And Annual Financial Performance
 
 
 
 
Three Months Ended
 
Year Ended
 
December 31,
December 31,
September 30,
 
December 31,
December 31,
 
2014
2013
2014
 
2014
2013
Revenues
$30.4 billion
$28.8 billion
$30.0 billion
 
$119.8 billion
$113.7 billion
Earnings From Operations
$1.7 billion
$1.8 billion
$2.0 billion
 
$7.0 billion
$7.1 billion
Operating Margin
5.7%
6.2%
6.8%
 
5.8%
6.3%

Full year 2014 UnitedHealthcare revenues of $119.8 billion grew $6.1 billion or 5 percent year-over-year, as an anticipated decline in people served through commercial benefits was more than offset by strong growth in people served in the public and senior sector. Fourth quarter revenues of $30.4 billion grew 6 percent year-over-year.
UnitedHealthcare earnings from operations of $7 billion for full year 2014 decreased $140 million year-over-year, including $49 million in the fourth quarter. The operating margin of 5.8 percent decreased 50 basis points, as advances in operating performance, service and margins were more than offset by 85 basis points of margin pressure from ACA Medicare rate cuts, reinsurance fees and health insurance taxes.


Page 4 of 8




UnitedHealthcare Employer & Individual
UnitedHealthcare Employer & Individual revenues decreased $1.8 billion to $43 billion in 2014 due principally to a decrease of 680,000 people served through risk-based products over the course of the year. Management expects UnitedHealthcare will return to growth in both the risk- and fee-based product categories in 2015, driven by strong client retention and new growth opportunities arising from increased participation in state public exchanges.
Year-over-year, UnitedHealthcare’s full year 2014 commercial medical care ratio decreased 140 basis points to 79.6 percent, and the fourth quarter ratio of 81.8 percent decreased 170 basis points.

UnitedHealthcare Medicare & Retirement
UnitedHealthcare Medicare & Retirement grew revenues $2 billion or 5 percent year-over-year to $46.3 billion in 2014, including growth of 5 percent to $11.5 billion in the fourth quarter.
UnitedHealthcare generated full year net growth of 15,000 people and surpassed 3 million people served in its Medicare Advantage program, despite losses of 150,000 people from the exit of certain products and markets in response to inadequate government funding for Medicare.
Medicare Supplement products grew 9 percent in 2014, as UnitedHealthcare served 295,000 more people, including 35,000 in the fourth quarter.
UnitedHealthcare’s stand-alone Medicare Part D drug plans grew 4 percent in 2014, serving 215,000 more people.

UnitedHealthcare Community & State
In 2014, UnitedHealthcare Community & State revenues of $23.6 billion grew $5.3 billion or 29 percent year-over-year, due to strong growth in people served through state sponsored benefit programs. Fourth quarter revenue growth accelerated to 37 percent year-over-year, with revenues increasing by $1.75 billion to $6.5 billion in the quarter.
UnitedHealthcare expanded its Medicaid services to reach more than 1 million additional people in 2014, including 135,000 people in the fourth quarter, and now serves in excess of 5 million Americans through community-based health benefit programs.

UnitedHealthcare Global
UnitedHealthcare Global’s revenues of $6.9 billion grew $552 million or 9 percent year-over-year in 2014, with increased revenue yields and hospital services revenue growth more than offsetting a 380,000 member reduction related to strengthened pricing for insurance products.





Page 5 of 8




Optum is a health services business serving the broad health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using advanced data analytics and technology, Optum helps improve overall health system performance: optimizing care quality, reducing costs and improving the consumer experience and care provider performance.

Quarterly And Annual Financial Performance
 
 
 
 
Three Months Ended
 
Year Ended
 
December 31,
December 31,
September 30,
 
December 31,
December 31,
 
2014
2013
2014
 
2014
2013
Total Revenues
$12.9 billion
$10.4 billion
$12.0 billion
 
$47.7 billion
$38.1 billion
Earnings From Operations
$1.039 billion
$677 million
$865 million
 
$3.3 billion
$2.5 billion
Operating Margin
8.1%
6.5%
7.2%
 
6.9%
6.5%

In 2014, Optum revenues grew by $9.6 billion or 25 percent year-over-year to $47.7 billion, with fourth quarter revenues up 23 percent to $12.9 billion. Full year revenues grew by double-digit percentages in each of Optum’s major businesses.
OptumHealth revenues of $11 billion grew 12 percent, led by expansion and growth in integrated care delivery services, including local clinical care delivery and subacute care services.
OptumInsight revenues grew 11 percent to $5.2 billion, including growth of 26 percent in the fourth quarter. Revenue backlog grew to $8.6 billion at year end, with external business backlog up nearly 20 percent, driven by expansion in revenue management services.
OptumRx grew revenues 33 percent to $32 billion and fulfilled 570 million adjusted scripts for patients in 2014, up 23 percent year-over-year.
Optum grew earnings from operations by 32 percent, rising $791 million to $3.3 billion and outpacing the 25 percent revenue growth rate, as operating margins expanded meaningfully to 6.9 percent for the full year and 8.1 percent in the fourth quarter. Each of Optum’s major businesses generated more than $1 billion in earnings from operations in 2014.


Page 6 of 8



About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives and making health care work better. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. Through its businesses, UnitedHealth Group serves more than 85 million people worldwide. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the Company’s results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern time today. UnitedHealth Group will host a live webcast of this conference call from the Investors page of the Company’s website (www.unitedhealthgroup.com). The webcast replay of the call will be available on the same site through February 4, 2015, following the live call. The conference call replay can also be accessed by dialing 1-800-283-4593. This earnings release and the Form 8-K dated January 21, 2015 may also be accessed from the Investors page of the Company’s website.

Forward-Looking Statements
The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These statements are intended to take advantage of the “safe harbor” provisions of the PSLRA. Generally the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “plan,” “project,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors.

Some factors that could cause actual results to differ materially from results discussed or implied in the forward-looking statements include: our ability to effectively estimate, price for and manage our medical costs, including the impact of any new coverage requirements; new laws or regulations, or changes in existing laws or regulations, or their enforcement or application, including increases in medical, administrative, technology or other costs or decreases in enrollment resulting from U.S., Brazilian and other jurisdictions regulations affecting the health care industry; assessments for insolvent payers under state guaranty fund laws; our ability to achieve improvement in CMS star ratings and other quality scores that impact revenue; reductions in revenue or delays to cash flows received under Medicare, Medicaid and TRICARE programs, including sequestration and the effects of a prolonged U.S. government shutdown or debt ceiling constraints; changes in Medicare, including changes in risk adjustment data validation audits, payment adjustment methodology or the CMS star ratings program; our participation in federal and state health insurance exchanges which entail uncertainties associated with mix and volume of business; failure to comply with privacy and data security regulations; regulatory and other risks and uncertainties of the pharmacy benefits management industry; competitive pressures, which could affect our ability to maintain or


Page 7 of 8



increase our market share; challenges to our public sector contract awards; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; increases in costs and other liabilities associated with increased litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of acquisitions and other strategic transactions; fluctuations in foreign currency exchange rates on our reported shareholders equity and results of operations; downgrades in our credit ratings; adverse economic conditions, including decreases in enrollment resulting from increases in the unemployment rate and commercial attrition; the performance of our investment portfolio; impairment of the value of our goodwill and intangible assets in connection with dispositions or if estimated future results do not adequately support goodwill and intangible assets recorded for our existing businesses or the businesses that we acquire; increases in health care costs resulting from large-scale medical emergencies; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyber-attacks or other privacy or data security incidents; our ability to obtain sufficient funds from our regulated subsidiaries or the debt or capital markets to fund our obligations, to maintain our debt to total capital ratio at targeted levels, to maintain our quarterly dividend payment cycle or to continue repurchasing shares of our common stock; and failure to achieve targeted operating cost productivity improvements, including savings resulting from technology enhancement and administrative modernization.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain risk factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong, and can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual future results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by applicable securities laws.


Page 8 of 8



UNITEDHEALTH GROUP
Earnings Release Schedules and Supplementary Information
Year Ended December 31, 2014
                                        
Condensed Consolidated Statements of Operations
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Cash Flows
Supplemental Financial Information
UnitedHealthcare Customer Profile





UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited)
 
 
Three Months Ended
December 31,
 
Year Ended
December 31,
 
 
2014
 
2013
 
2014
 
2013
Revenues
 
 
 
 
 
 
 
 
Premiums
 
$
29,375

 
$
27,707

 
$
115,302

 
$
109,557

Services
 
2,765

 
2,361

 
10,151

 
8,997

Products
 
1,127

 
865

 
4,242

 
3,190

Investment and other income
 
166

 
184

 
779

 
745

     Total revenues
 
33,433

 
31,117

 
130,474

 
122,489

Operating Costs
 
 
 
 
 
 
 
 
Medical costs
 
23,434

 
22,504

 
93,257

 
89,290

Operating costs
 
5,845

 
5,054

 
21,681

 
19,362

Cost of products sold
 
1,008

 
757

 
3,784

 
2,839

Depreciation and amortization
 
381

 
350

 
1,478

 
1,375

     Total operating costs
 
30,668

 
28,665

 
120,200

 
112,866

Earnings from Operations
 
2,765

 
2,452

 
10,274

 
9,623

Interest expense
 
(151
)
 
(176
)
 
(618
)
 
(708
)
Earnings Before Income Taxes
 
2,614

 
2,276

 
9,656

 
8,915

Provision for income taxes
 
(1,104
)
 
(849
)
 
(4,037
)
 
(3,242
)
Net Earnings
 
1,510

 
1,427

 
5,619

 
5,673

Earnings attributable to noncontrolling interests
 

 

 

 
(48
)
Net earnings attributable to UnitedHealth Group common shareholders
 
$
1,510

 
$
1,427

 
$
5,619

 
$
5,625

Diluted earnings per share attributable to UnitedHealth Group common shareholders
 
$
1.55

 
$
1.41

 
$
5.70

 
$
5.50

Diluted weighted-average common shares outstanding
 
973

 
1,014

 
986

 
1,023



1



UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited)
 
 
December 31,
 
December 31,
 
 
2014
 
2013
Assets
 
 
 
 
Cash and short-term investments
 
$
9,236

 
$
9,213

Accounts receivable, net
 
4,252

 
3,052

Other current assets
 
10,068

 
8,115

Total current assets
 
23,556

 
20,380

Long-term investments
 
18,827

 
19,605

Other long-term assets
 
43,999

 
41,897

Total assets
 
$
86,382

 
$
81,882

Liabilities and Shareholders' Equity
 
 
 
 
Medical costs payable
 
$
12,040

 
$
11,575

Commercial paper and current maturities of long-term debt
 
1,399

 
1,969

Other current liabilities
 
17,184

 
14,337

Total current liabilities
 
30,623

 
27,881

Long-term debt, less current maturities
 
16,007

 
14,891

Other long-term liabilities
 
5,910

 
5,786

Redeemable noncontrolling interests
 
1,388

 
1,175

Shareholders' equity
 
32,454

 
32,149

Total liabilities and shareholders' equity
 
$
86,382

 
$
81,882




2



UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
 
 
Year Ended December 31,
 
 
2014
 
2013
Operating Activities
 
 
 
 
Net earnings
 
$
5,619

 
$
5,673

Noncash items:
 
 
 
 
Depreciation and amortization
 
1,478

 
1,375

Deferred income taxes and other
 
(415
)
 
(82
)
Share-based compensation
 
364

 
331

Net changes in operating assets and liabilities
 
1,005

 
(306
)
Cash flows from operating activities
 
8,051

 
6,991

Investing Activities
 
 
 
 
Sales and maturities of investments, net of (purchases)
 
799

 
(1,611
)
Purchases of property, equipment and capitalized software, net
 
(1,447
)
 
(1,161
)
Cash paid for acquisitions, net
 
(1,923
)
 
(362
)
Other, net
 
37

 
45

Cash flows used for investing activities
 
(2,534
)
 
(3,089
)
Financing Activities
 
 
 
 
Acquisition of noncontrolling interest shares
 

 
(1,474
)
Common stock repurchases
 
(4,008
)
 
(3,170
)
Dividends paid
 
(1,362
)
 
(1,056
)
Net change in commercial paper and long-term debt
 
391

 
152

Other, net
 
(314
)
 
602

Cash flows used for financing activities
 
(5,293
)
 
(4,946
)
Effect of exchange rate changes on cash and cash equivalents
 
(5
)
 
(86
)
Increase (decrease) in cash and cash equivalents
 
219

 
(1,130
)
Cash and cash equivalents, beginning of period
 
7,276

 
8,406

Cash and cash equivalents, end of period
 
$
7,495

 
$
7,276


3



UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION
(in millions)
(unaudited)
 
 
Three Months Ended
December 31,
 
Year Ended
December 31,
 
 
2014
 
2013
 
2014
 
2013
Revenues
 
 
 
 
 
 
 
 
UnitedHealthcare
 
$
30,434

 
$
28,786

 
$
119,798

 
$
113,725

Optum
 
12,876

 
10,437

 
47,746

 
38,117

Eliminations
 
(9,877
)
 
(8,106
)
 
(37,070
)
 
(29,353
)
Total consolidated revenues
 
$
33,433

 
$
31,117

 
$
130,474

 
$
122,489

Earnings from Operations
 
 
 
 
 
 
 
 
UnitedHealthcare
 
$
1,726

 
$
1,775

 
$
6,992

 
$
7,132

Optum (a)
 
1,039

 
677

 
3,282

 
2,491

Total consolidated earnings from operations
 
$
2,765

 
$
2,452

 
$
10,274

 
$
9,623

Operating Margin
 
 
 
 
 
 
 
 
UnitedHealthcare
 
5.7
%
 
6.2
%
 
5.8
%
 
6.3
%
Optum
 
8.1
%
 
6.5
%
 
6.9
%
 
6.5
%
Consolidated operating margin
 
8.3
%
 
7.9
%
 
7.9
%
 
7.9
%
 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
UnitedHealthcare Employer & Individual
 
$
10,721

 
$
11,423

 
$
43,017

 
$
44,847

UnitedHealthcare Medicare & Retirement
 
11,494

 
10,950

 
46,258

 
44,225

UnitedHealthcare Community & State
 
6,517

 
4,767

 
23,586

 
18,268

UnitedHealthcare Global
 
1,702

 
1,646

 
6,937

 
6,385

 
 
 
 
 
 
 
 
 
OptumHealth
 
3,017

 
2,508

 
11,032

 
9,855

OptumInsight
 
1,487

 
1,178

 
5,227

 
4,714

OptumRx
 
8,507

 
6,868

 
31,976

 
24,006

Optum eliminations
 
(135
)
 
(117
)
 
(489
)
 
(458
)
(a)
Earnings from operations for Optum for the three months and year ended December 31, 2014 included $341 and $1,090 for OptumHealth; $367 and $1,002 for OptumInsight; and $331 and $1,190 for OptumRx, respectively. Earnings from operations for Optum for the three months and year ended December 31, 2013 included $242 and $949 for OptumHealth; $181 and $831 for OptumInsight; and $254 and $711 for OptumRx, respectively.


4



UNITEDHEALTH GROUP
UNITEDHEALTHCARE CUSTOMER PROFILE
(in thousands)

People Served
 
December 31, 2014
 
September 30, 2014
 
December 31, 2013
Commercial risk-based
 
7,505

 
7,545

 
8,185

Commercial fee-based
 
18,350

 
18,300

 
19,055

Commercial fee-based TRICARE
 
2,895

 
2,910

 
2,920

     Total Commercial
 
28,750
 
28,755
 
30,160
Medicare Advantage
 
3,005

 
2,995

 
2,990

Medicaid
 
5,055

 
4,920

 
4,035

Medicare Supplement (Standardized)
 
3,750

 
3,715

 
3,455

     Total Public and Senior
 
11,810

 
11,630

 
10,480
International
 
4,425

 
4,550

 
4,805

     Total UnitedHealthcare - Medical
 
44,985

 
44,935

 
45,445
Supplemental Data
 
 
 
 
 
 
     Medicare Part D stand-alone
 
5,165

 
5,155

 
4,950


Note:
UnitedHealth Group served 88.5 million individuals across all businesses at December 31, 2014, 88.5 million at September 30, 2014, and 88.2 million at December 31, 2013.














5
GRAPHIC 3 optuma01a01a01.jpg begin 644 optuma01a01a01.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`1@#B`P$1``(1`0,1`?_$`'X``0`"`P$!`0$!```` M```````)"@8'"`4#`@0+`0$`````````````````````$```!@$#`P(#`@P$ M!P`````!`@,$!08'`!$($A,)(10Q%18B(T%183(S)+2V%W M,E'C4:X2/D\GV]QVZQ%/OOFL?%LE"'E;#*-2&*JHR3``;(DZB"JNKN!MDSZ# M#^/WD!IN3?D\/D..:T28E6S,K*=(_!:IR#\Z.SE%PLZ*DM7E3.BB5(BQUTA$ MP%%8#!ZA(8BLDX2270537073(LBLB+&`J39FR1.X<+''\1$DQ';XC\`]=!71SPXF>3V2)R_NJL\%HXZ(R MN"F4[,\=7&!U21;<[M90J*KI5-05EQ#KVH*/`DL; M:-:D=F2.[25>0+5X95%RZ61:%4,\1`-S%`@=13`(F#I`1T&Q^+O)WDYQO7BJ MQ9F9\IXC;&!LM6%9IDXL->:#O]NHRKU1NLD1NH<3BR<=:"GJ4@I"(&`+`>-L ME53*]4C[A4'BKB-?D#NM'J`LI>)=@4!5C9B..8RK!^AN&Y!$2F*('(8Z9BF$ M,]T#0-`T#0-`T#0-`T#0-`T#0-`T#0-`T#0-`T#0-!$5Y1N1$Q28RE8=ITP# M&1LB@6RZBS<"5]].QKHJ<-#."E*)4FDDZ2`JB9DS`)?4#EW#X:"=[C13TJ_C*$GG48XC M9^Y,6L[*H/!(9TU1<`=6,8[D$0(FBQ5*<0]!$Z@B8`'T`,`S)PXH&0S.YRKD M)2[6NJ#A=1@F'R24-N)EB.XPHE1:.'&_Z=`"[&]3$/OH(],U2N6^*$C'Y8QR MFK#2E-79Q>0::Z[ZE8OM+$R39H>6:)*`@Z5ASC^JR*7ZRW27-TGZ0$@A*_QZ MSW3.1F,X/(U/6*A[]`J4Y7EG*2\G5YM(`!]#2/;`G4=!3U26`I2+I"4Y?0=@ M#>.@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@\*SV!C5:_+V&1.4K2)8KO M%`$Y2"J9(@BDW3,80#NN5NE,@?A,8-!7VR[@IAEVWV3($Q;[.G:K&]7?NW+Y M5K*L$0$>EHQ1;G1;*M8N.;`1%%--0"II$``_*&,<8ZCC>HYPK51RYEG%C>L1 MKEW9&@R-EC6:,TXBCH"6M.FLF!6?+$75>*(*J`DC+LC=:"RB9TTE>D0'J+ MOH+,^+'/?D!7L9UR$IR[69 ME)B45"=4CHED[436;-.Z@P:/'Y$CLFA73HQE/O!$P`@`@41$-!`??\Y7G()E M&SF0"$A!Z@"$A5EFK91,1$2C(N>Y[E^/3MOUF!+TW`@:".&W7L'V0$Y5L?JB M8=08MN4H=95V76)9!8""/3U.51,8-OB!2_';02?<9.=.=N/;N%B*_-JW;'1G M;;N8[LJAWK$S1THCW$ZW)G*K)5QR=+]$"1CM2G' MU41TRG"-^P]B0.3WC?=5G*1!C`!P`X!LH1(_J=(X=92F$=O3?06A/$+66;'B M'$WE$A".LHVZRV=TF`H**-4XET6H-V1ET0W43*>O*+E`PB8GN!`=AW``E'T' MS56203.LNJFBBF7J455.5-,A0^)CG.(%*4/QB.@\Z+G8.;2%>%F8J71`YDA6 MBY%F_2!0@%,=,5&BRI`.0I@$0WW`!#0>KH&@:!H&@:!H&@:!H&@:!H&@:#\= MU,#=(J$Z@^)>LO4'_#??0?O0-!_.X:-':9TG;5NZ24(*:B;A%-9,Y#`(&(-5VOU#4T252PMP73,D9=.1AB- M@77(4WV1<$7*'XMO300&W(P%T:*IBJJF MP8294`K\X11("D(=8[%03_G`/QT'"^):58J=:WE:R]#/J!.8N643L<7<40AE M&ZZ&Y8LACO@(W604(/610ACD4*GU%,("`Z#=,WRBQ-4W)%F5L=RTDV4!1$]1 M;NG:R"I1W!1.2*9FU2.`_P#,581T&U+AY5Y/*^'T\;VBKV*0;P%EC9-W>I%] M&I/Y5B5-Z6.8S3!DFL`F:.U0.9P4QS&*0@G*)@$XAS[,9JC;)&+QSZFLY**> MI"!DUI;O%4(8HE*JBJFRZ4U``1Z3E'TT%FSQYT..QUPYP?7XL%BM'=<>V@A5 MW'N5"_6$]*V@I#*>V:"`IIRI2B42`)!`2[CMN(?'G9S5I/"'#BN0I]A]36^> M?!7L=45%XFS<62PJH*+G7>.!`ZC*O0K9,5WS@I#&`H%2(`JJD#05<*/0/(3Y M;;E<[4%X>NZI!R0$>K62T2U4Q)4E)!S[EE4ZW7X5NY;O7TU!2&!K`X/AVU7.&OL>DW,F5^\AXX8^&= MO#L&ISKJ>V6,J+=(X@01^SH)`/$]Y5+CENUQ'&/DI,-YNX2;9=/&64GYFL;( M6)>.;"H:G6\VZ3>3L[M(@BP=$325=BD=-;N.#$,H&I/[@.WVVL9.XYIURVVJ MMH.*%>EG:-=LDU!I.CI3\,":CE**?,R.%$R"(%$X")0$0#XZ#FW'OBH\A^3< M=TO)5:S/'!!WVGP%U@6TAF[(C=_\KLL0UFHQ%\1)NX1;._:O"`J4#'!,^X;C MMH->-\S<^O%#GF)JN1[38['#.6S">?T>P7&7N>.,BU9P8$WKBM20E[`WKQ:?F.\3Q^JM(Q:TF9^5PI%BT+TS"/:$.ON#U?#I]0Z2QSXM?(]E M''])R55\IQH5N_U2`N4`$CGV_MI`(:R1;67C??-DF3A-L\]F[)W$P4/VS[EW M';0=H\L<49XXK>(&&H&4+G(!E&*SM!.7]AJ]\LH!H.J_!!/S]BXC79[8IZ@@@J("'X/NS:"GCX8+Q>)WG^E&S MMWN<[&_P^RXI\MF[98)>.[B#J+!!3V,C(N6O<1`1Z#=&Y-_3;0:S\OE]OT+Y M`\V1D'?;S"1K>.QF+>-AKA9(J/;F5QM6%53(,8^3;-4155,)S"4@=1A$1W$1 M'03U^);GNZYZTZ07CHRW)%*MW?G(.8LQ98 MA444$UUTC);E4$"!Y'E\YYEXP8E'$&/),Z6<\RPK]K'O&2J8.,?T58YHZ8MZ MQNKO-Y24#O,H@2AU`X*JN!BBW#J"$?PVY%N\GSRQO#V"X7:RQ\C6\@H^SF[E M8)1@V7;TV8=I/%&,D]>MW!R@W$A0Z2B4QP,!@VV$+'^7^(D%;LN9,R##XQK[ MYS8,"6DD)-'?H-':^=W3Q^A#2O;5?I':27RYK-JP],J6(H&):DP@T#&'LF&P*R-CDWR9=@ M+UN'+PB)A]1'VH!N(``%"RIXY\?P6-^$?&V$@2-Q2E<7URZ2;I$@`9[.7IH6 MWS"ZY^M0ZJB;Z9.B7J,/0FD4@;%*!0#M?045O(KCV)P!Y&LCQ5`VBF33(&/, MF0;6))\O&"DK6VKMT59QW:ZBMO9R[M0R!B!TD*8H`7TV$.^O[A4QU\C<95!# M!ZO;.1-2B++3L,8YK]C@%(V MUN):-G(&H1,9*QAF;2ON#KNFK]JHGLGUE/T]11$H@.@@A\K7-.F\X\T8]@\) M04M+4_&C":KE:L2T<];S>0IVW/(=5ZK&0"Z"4BRB6ZL2B@R36(5RX.8ZAB$` MQ"`%L_B%0+5BKB[@+&UX08M;92,54VM3K:.7@F^X4?T>\7/Y`8D_<:$T'!GG4 M_H1??S7G^?-K_`'3I&@G`=?\`C./^PK_AFT%,KPF?[AB/ M\N\P_M45H,OYO5:`O'FQB:5:XY.8J]ORKQLK-CB55%4DY*#FZO1XZ39'51.F MLD#AFX.7J*8#%$=P'<-!J;/.(\H>(+FE0;C0K`K9JT<3V^C/W1EXLEPHBDG[ M&U8XMY&"PB*J"/0W<'(/0L!F[HJ91^[*&0X6QCE[S$\V[+DV^E6KV-H9U"O[ M\_CCJ*L*5CZ-\L/&;C?-9[!>L8J(8ZRD_20<`W2(1&B3SQN(]XTE$LVW=BG\BF.QW3; M(7R(X>F<$U+C?EFXU;&^1<6HIU>GJ6:690,5D"IJN7"\&>(?/A:QQ M9V&*N#!=F97OK$227("@J*=`2I\A^8F`.,N/I:_Y'R%7"E:1AW\%5(B;B9"X M7)R<@^PC:M!IO?=2*K]82E!8`!LB41454(F43`%/_"5,R[Y-^?3VWI)I0CRP MWIEE6]2J20NHS'=`K_P#< M.B*>3^-@[]0DQY?1W$`#<2S\+ZB!0`H;[?@``T&\',GSF1/8.H)%@W?V>MQLV^9LNY&++ILT5WIDTQ,F1%HN-V0;(MX2#SFUC+$C2]\<,MVBMT.,M=C-D"@6VR2241$OK`]80T'+U-[)NRDC63ER MUBTG+,ZZZ2:ABJ)`(J&3*<)Z>6O,+#/&K#-SN=CR-5VUC/691.AUUC+1\I8[ M+:'T8Z+7$(F#:.COG;4[\4SK..D&Z*!3'.<`#U"MWX%J3/V'E[;L@FB7[J$J M&)K.C*SZ0E;1;.PVR:@$6;)81:J$=NG[9%VQRS_P!] MJC?SRXK_`/Q*!H+`7D'X5P/-O!CJBG>(P>0ZHZ<6C%EG7W!I'6@K%9J:*FA3 M177/6K"@8$'@)E%1,Q4ER@8R($,'JX^J.@WMOIOYM M]Y\Y[>_3[?[WI_)H,]T&+7CZ.^CK1_$/Y%]"_(I/ZO\`J?VGT[].^T5^;?.O M?_J?R[V?7W>Y]GIWWT%0+D;A+P\V^P3P@^L5)D6[)-0OH"H(+%+_P!!OP!:O\?+3A`PP^]9\'I.O35, M;3!4;?+-TYI*[2-C(S2!)W>D[7'Q-M([69["U!PV0:@GU>V(4G4&@CW\RV*. M+F1KUA-UR"Y7K\HQ6(,=Q]8N1H=]7C6J!9U2+0B;":!DP+(PPR[%,BXM5P!9#N=!_M`.@W6^] ME[)Y\R]K\N]JX]_[[M>R]EVC^Z]Y[C[CVO8ZNYU_8Z-]_305!>5.%O#[=+C: MY;$O,MSA:?5D%SOJPUPYEK(N+T7I4Q(NC!.(:DM_;,%710.)FT@]1*)C]`"' M24H"_B3'H&JS8+6@W04%RXV5V$AM!8OT#05A.`.$N&=3Y M\0-KQ;S;E)9<.UQ4IQ\R72R.U9"&L2 GRAPHIC 4 uhclogoa02a01a01.jpg begin 644 uhclogoa02a01a01.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`+P#<`P$1``(1`0,1`?_$`'\```(#``(#`0`````` M```````)!@<(!`H"!0L#`0$`````````````````````$```!@(`!0,#`@,# M"@<````!`@,$!08'"``1$A,)%!46(2(7(Q@D&0HQ);=1<3)",[-U-G1$!`````````````````````/_:``P#`0`"$0,1`#\`[_'`16T7:KTU M)F:PR[9BXE''HH:,`1<3$[("F90D=!1#<%9&7?JE(/2D@F91N-LGVG(M:=O;&1XE>!?8]CY$SU$84@$80359ZBF("HLY<"!1 M*9-$?IP&V>`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`.`Z MP/E]\[60M03\L2WD5FXEU>[8N1_.( MP1<0PSM*MQ2H)I(0=8;./O1C62:#)$?J1(!^O`-$Q#_S)J5_U\VW_P!_.<`V M[@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@/G`^?W_NN; M(?\`!<*?X-4K@'$^!+_X>8D__2.;_P`&87@'#XA_YCU*_P"OFV_^_G.`:/=) MF>KU3L$Y5ZB^OMABHMT]AZ7&2L+!R%F?H)B="'9R]C>1T%'.'A@Z2JNUTD"C M_I&`/KP"U-&O)X3>G)F4IFBX M.V24[.2#Q[".$NZP;KM40(!U%0*8HB%G1&[609/<63U`5T_S!'2$1"I7Q]E= MU<<2FQV7$CZR255A\D-S(7%2==-Y:7BU4B1)&HS*9B'[CPE#I^-<7Y0M*4]#0N6I_$-4K4:O&=4\A8\URT'"5&*E8X%R^ MC6;R$\D5\(&-Z8B:AON`@\!>G`'`0O(MBLU3I-BL=.HPF+4_BZ^R<@@:L^0NV[>ZVV79K%&H.75*D@D8V-(*9O&'XVPY@6B[$]KUL0K"2US!I"!6 MEHY:H&N65\<8]H,J^JL[?\@3F/@8# M?&!(YRO3&4%"621L;E^@PD2K+.`;`T1Y`0RG68"\`S[@#@,)>0/=EQH-A-SG MZ4P3?M`5"\^0,0 M=OA+&@9U!5)].1[:P2K+)J'2.5,0)^H8A@)S$H@ M`3C@/G`^?W_NN;(?\%PI_@U2N`GMI0^'X% M%50@_45B"*GW#]`(/]O`-]PMU.[#J(*9>1ELS[;3!2\^KFR]1+E%4!*`]10. ML`<_[!X!M_`=;+P`_P#N_P"7/_[LRW_KN3.`81E9KD-YOEEY+%%RA M5%?5NVV*HC>X2+=1VP^17RQ)&JA.5PTFW?M6YVXB5XD9'N]PH'$@$,"T=8]X MO)UN'H/E;:*IY!PCB21U[:9B?RLW*8C"T$SI9L=-GEK6J<3"J69HSQY28&J% M;,CR7]X24A+*J<@02;B*P67LKY"=E;?X9,=>1_"MFI&*[B6IP\QD;'D[C6*R M16+?+/[]&XVD&D8XL=H"'JN=,OX*GHN@FQHFX@83-D?7*M83Y,N:K6SL'E[ATG]J4!G!)FC&[ M0@&$%3J'!0@,6VTV[V)U0@-8-X69E<78[NQ<>RU&Q=1JT+^.-. MY#LE`2O-IF94M*B99`J;4DLD61=&$YC))IG3,'C#[8YTUFW\P[I-LQ?:]FRH M[28WG+1A7,D=0HW&5EKN1J5Z\]IQ[;*]!2+^O2\',1[0CB,>(%0=-UER-U^^ M!NZ4*FPCN'N3OO,[29EU4N&,L98`UNR#.8PQ+2+CC=6ZRVSMIHS`LM;'5UMY MK!%/L<5J>!9NTBQAVZKIJ5V"R_>%(4E`Q/XJWYY;P4;W2RK4S!66FMWI-9@= M0%3,%I'';=XJR,L!2`J9HHL*8GZ0ZA+SY!_9P%L^%?;F(Q=XT<"45UK_`+;W ME6*+D[O6G%^O5NO5(>^OR9*O>?9ZVQ#V:;TO:O("U>I_6$=)V>X62*HL34ZNHHJ53VY1Y,2"17AQ M*,\E8KS!<\90&>\(U7&B=/'"L%F M5@:2@YG&-]"=?SMG8?LKS6 M:N:9Q<1^/Y^R8-89#J>='K^J25F--S5MLTG&`UAWJ\:4K5G")%4+%N".S.SJ M&!$H8FVSW#L.]G].3F'8FXUN*JMTGXF&K=QBX`SD:^>R4O/%7K=/!M5ZKG6$A,?9`F,,OL:4%[CCW* M$H^3*7CJA,1O]Z6;6J*D,G@N%M7(S8`O$I,$1.!#&45,L(3WRX.<]XYV(\+K MV?>U#.V?8;9'*RD'\=K+W%%.MUBD)3%S6EQKF%MBR;D'SDYT4 M%EB$()BI@&SJ?M7N'@#R583TMV?R%BW.-0VCP[;LA5"R4#&"^+W^++O4"SS^ M1JR*![)9%+135F<`LBW=/5`D#"HDHK%<+E_*&P&2:%!2-@OI:[$6B0:5Z$H=;;L"(-4D">Z2ZRY!*Y;%- M^F%80OE2SQFG6WQQVK&.-)VN6O>?--IQ!-H-DXGR&9_\=^9K_6O\!G MC$^<6N/HJD6E@C-OHV#>UN\U"OR)*K-C&R,L59NX9D8"L1`2J$+W0[8+FC/( M!Y5[58_(OK_CXU)ROF72NP+R419<=89:H/KQ"MGC."K%(K=$DYR?;*3UP>O' M,M)&55>+M(R%<-6?6Y=(+I!M3`&X&W&^^9\J8;Q?;*[JK'ZJXZQ9$YXMBF-X MG)]JLFT5WKJKZW8[B(6U29:_6J!C::B'[-X/)Q*O5T1(1=N7D<`X&AUCB?(; M:+-EG,?13=EM0+1D+=:P>5.]F:Y7KJQA4?5,#JN3 MH.HU0K99'J446![O`?/1_J-<:S=.\F5JMCV,>HQ.8<7XMLU8>@V5,C,J5^`3 MH,NV8F*4_JW;%_7$RJ)I\SE[R?,/O+S!YOC2Q5(ZLZN:WU>^QZ\'8<.4S,&W M>:HN13!NO4[GF%I[9B&@S2`AUM+@M7P8G.R4Y."'-T&*40'@&2:XU203RIK_ M`%1ZF8)#"^OMAN=U3.4W5%W7.4X211B'8B'V218LZJ@E-R,"8?Y^`9[P'6Q\ M+KB,P?NCY9]=,ER;.I9;F=FUISRI(J2MV.)>7O#J/N%80>&2-,Q"C.<8 MJF4;BH!"/$A'Z&^@,-4O5(G-UMJ,L-+?6R8UPKIQ0\.9"OCF:CFU/@P$;9(%_. MPK/=&0F(1G+,7,M$Q\S2Y5U$/I*-27,\8LY5L`J-U5"%36*`B01Y#R#,-CR5 MCD_]*U`58M_I1K,M#1E;2KA+1"'GCV)+9`\VK`EAROAD!F4H4?6&;=OO%:"" MPE[8@;@-9[R6VJ3L3_3SY`A;-7I:B1>P&'8R4N<=-1KRK1DB>C8V0*QD9U!R M>-8NP7C7!#)JJ$.0Z"A3``E$`"`^4V4;YAS1JKNKD"JI6;4G5O=?(&M^7IVI M/9]>)2Q*I(8[9N6C*!?]6=FLI66_PED>MHR25K%B MJ];J<]88>"G(-U>:`D2KQ[N&?.T'C=>1:/&DQX7*GSU1_:X-F6D>LRI=73(;8+A\G\>*\;.4U41 M==H%4U"F)U`8!$$"ZT8Q?;5^%G?S%&%YF)M^7*?M[([`1.-X60:OK=:*;6T* MB]<.XJ`14-)O6[Z$%XLT,1(2N'#7LD$53`40>)W(WCUQWG]]B.@Y?EK M%CBHQ<)A^7R9?I>=N&Q0Q+.N,,1HTE>[/G3:YN,B*"P%%-CW6:)S.>@K"E,@L8-]%W+- M=CL]I8(1L!'+'4C57!N@K10QB<`M*F[,8M9_T\>6-6WEC@VV3EHBSWUQ&+V& M"0>,G;W;FOQ<12EH11\6;&US$:B\E$$`0Y#&L55AY%`!X!GVW%MJD_E/^G+R M)!V:OS%!:Y`JD(ZNL9,QSVK-9D:=B)+VEW.-W)X]K)`LP7(*"BA5"J(G((`8 MI@`(QOGMC3LK[S>*JS66W8SKL1B[R&[%4YC(-+?&IM%,84FW8RI$!D6PK/I( MQ8R-L5BB))NF],*4>Y%F8R!A*!AX#2F[5OJ=<\\OBXG;#9Z_`P;G!>8V[>9F M)F/C(M9::C,AL8=)*1>.$6AU)5XZ21;`!_UU5"$)S,8H"'JO!1/0FLL?O1IK MG6>AJ#E_#^S%SR)+1MXDXZ`<67&MMB(EK%9&C59=9J66JCY.OBN9Z0ZB":;I M(3F*"@JOFIV'E\8*K36/X7 M5VDXHKBZMV?66QYJR[/9>Q14;6YAKO?)M^]R)9F]GEG*4BY(\7YGAGI2_P#A MC@4-;^)O)F-)/R>^9-".O]'?O;GG6B.::BTL\&X=6QC$DO327<5A-)Z=6>:1 MKP2IN#M.Z1)02@80$0X"@=6]5\`4WRG^0S7ST-*X^JULJD?99F!&<:INVXF<.&RC-ST@4A#CP#DM`J!J[0K[M=& MZB8;K=+Q6QNU'KLWEVL6VR6R.S7E*(@YF3OQ&[Z>EIM"03QJYL3>-<2#5RJ# MB57>H*#W6AN`9?P&7=G:;K??8BIUK.]DQW4;$]G.K#UCM4_5Z[<8F\)E2]*[ MQP\GG31\YFTE!2%1LS$XKEZ2G*/VB`+TC:!=*P]D("2?XER!4:CD!HHUFPR? M2ZUCBP9/65Z8:S9Z?/[#-9#L5V9NA`Z%?/R2.L7I3YD'[@9%KY0J_0D;RU<7 MV(R+EZ:L"$[FB?9/6!Y!*R/FHFC(MQ"-'"R];AXZ.`4XYJL1,PH`8X!]W(H: M+X#%&T<7X\Y:>J[?<=74I*V%;@I339^F,5PMK%D5=7Z5MS=GS"<.P]1U\RMC MBD)^KF'/GP$\AT]-T=?5TH,=:AU82)VW@L%<8K8%$I)9L4POUDSJ4%8XSP)= M9EC&,9[TB815YKW+^$Z.[S^G7P%7%_E6>U)]/\OOV/W=3M=/[<_:O??;D.]V^7\)[O[3 MVNKE^MZ;IY_9RX";SZ'CYKZNH>HKON<^8\^?`7;5"X$)A>.+21Q(.O)*FY+%C63T\^'!I`)K@\]&> M,,:EGJ_;!7NB41:B'7U?ZW`5+J^UT4:'MI--#:K&64516O(ZXN\5/'`'47<" MT"SJ8Y67731!R"O83Y_9ZO_`&'ZG`2;"?[&/F3C]N7[ M3OR%["[]5^$_P_\`,OC'JV?KO4?!?[[]A]=Z?N]7\/W>WU?=T\!%J4U\=)-A M9-WCLVFP[3JNI%*6)3GF&3YS"1(DN,P+IE#+FNZ,F*'=]6<4RKF)U=T1#GP' MLYAKH".RT6[GC:D?N](NS1AR2KO$1=A!>F;D-'"Q9.U@R`I(^CZ>PH1,5P1Y M`0>GEP%7)(>)9"1M`D-X]#2J]PE5[AWG&N;A^6]'3`LR6=!PJHNWL@)D_B$U MNEP'U$Q0YCS"P;0AXZW6`2H6XVFA=7U+8L"1IASA9I@X+V"ZQG'IG*ZJ-&2M MWJ`5[@IF!Z)NL#?ZW`1V?#Q=`6*"T_L(Y!4J\$)\A'7HP_!0C2!5/;#28B(U M3VCI]O%+^$]/R[/VKHOYO\`VI^O]@C?QG^5?Q%ZOXMZE'VCX+\N M_6]@]9V_3>W_`,-W.GH^[EP$8V59^/-U::>;;P^H!;JV;IKT;]PC[#[.S&8% M<'Z"UXN07"$FZB_5=7Z:(';BIS^WGSX"6;&M-+'N.:PWVP-K43%)W;$:6;.[ MS&K"C@^*R(:.^*.KPNVAB.AC0+V@9'`PM^0!]G`0UZU\=1K-@59^;38+Y>E<=[XM\9_O[UWH>[U>D_4[77S^WGP$XVE::6O:]7 MF^YY]:R5@TFL:IFV.>XV81?NY"(F<_&W.15VR)9`4@)W0:'!02<@-S#EP%UX MQ#&04"JAAKX-^+@BD@I/XS&!-0_9`.H"/Q GRAPHIC 5 uhglogo1a02a01a01.jpg begin 644 uhglogo1a02a01a01.jpg M_]C_X``02D9)1@`!`@$!+`$L``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!`!+`````$``0$L`````0`!_^$Y8&AT='`Z+R]N&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O"UD969A=6QT(CY"87-I8R!21T(\+W)D9CIL:3X*("`@("`@("`@("`@ M/"]R9&8Z06QT/@H@("`@("`@("`\+V1C.G1I=&QE/@H@("`@("`\+W)D9CI$ M97-C&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M M+WAA<"\Q+C`O(@H@("`@("`@("`@("!X;6QN&UP.DUO M9&EF>41A=&4^,C`Q,BTP,BTP.50Q-3HU-SHP.%H\+WAM<#I-;V1I9GE$871E M/@H@("`@("`@("`\>&UP.DUE=&%D871A1&%T93XR,#$R+3`R+3`Y5#$P.C4W M.C`R+3`U.C`P/"]X;7`Z365T861A=&%$871E/@H@("`@("`@("`\>&UP.E1H M=6UB;F%I;',^"B`@("`@("`@("`@(#QR9&8Z06QT/@H@("`@("`@("`@("`@ M("`\&UP1TEM9SIH96EG:'0^,C`\+WAM<$=);6&UP1TEM9SIF;W)M870^2E!% M1SPO>&UP1TEM9SIF;W)M870^"B`@("`@("`@("`@("`@("`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`F(WA!.S`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`F(WA!.RM' M36]32C5G3C)O>E-J3TE(26QL6&YI>#@Y6&QJ8G`U4#%+,3`R-U=5;35K=30O M5E9O*TIO<2]$2E$X=F)+35)G1#9X8F1L17E046$F(WA!.V5/*U4O3F8U-BM: M9DY/=2M83%1Z0EE1,U=G>7E26$TP=')(-F)M2UIO4U4T>$4Y5G)U37HX;5!$ M0TEK460S07@U33`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`P<6$U:UIC94Q'0F-B=GHF(WA!.V-F1FMY-4-A;%9E4V0O;#4K8BMP M6&9L,WI83#5Q:6E/;V54;5E8:S%Q3TM49V5O1D-G+W1L-$=8C99 M0U5E2&Q*'DT5$AI*TQ(16,R M4U`F(WA!.T5*8U!W5$AY0BMA;75A,S53.#!X-G)(1D(U<3AQ>%1I-#1,4TXR M:FIK-%!W2C9I4T9G-$7)4235T3TEY:E@P>5I99%%:4FQF,5(F(WA!.U1R M.&LO3G5T*V$O26M/B]!1%IQ=C5A9610348F(WA!.S-.1612,&57-D=N M6AH1U1G25!V=&A'95DT*T]X.&LS:C@O+VU,-6TX=F58 M9&0X=%=X:%,Y4FLF(WA!.W9964E5;E$S36-R>%-++W%!;4Y+;VI)4S9J:5FQ" M-7!U%I)6'I!22LF(WA!.SEL=#$O=T-T53)F+T%'>FHO=T)1 M5!C-R]N3$0O;$1D22\W84DO-4U363EN9E=F8W9A4#!$ M,W924$\S+T%*2W8F(WA!.UAV.$%T:%AF+U5'*UEU3"LX2#E99F4U5U@K-U`Y M6#E$>#,X;E!Y"M2C%W;W761H36IS44]T15)34V8V-5)O M;T4U064U=C%S=TU:2&4X-2].:E0W5)N-5%F;%0F(WA!.T8U9SAH-EAQ9S@Q87I93DM::DI95TXQ-F--6$,U M:U%C56]E4$QH>2M:>4]P,4A$36IH0E1P=%!X44(T:4=59C@U26%V8U)E5#E0 M.$$F(WA!.TLY9TAN,4QZ1F1X5S!52VUS:VMC3$MX03A36E1'=C`U5&]9*W-Y M4$M,9')P96=22$]4>G9Z+W)'2]W1$]Y-&=K+TUZ.'-,:$I&340S,%5I>3$K16\F(WA!.V)U,DEA=FA42TY) M4#-C+V0K9W0K<5`W>4AV.$$P:#=F1&17,'A):&U346IC:$=$52LW3F51-T%% M4$,O>50O.$%*>2]M3B]Z1C-8+U4F(WA!.V1*;7@Q9CA!9%$Y,S9(6&%4*SEN M-R\P;U0O;DE+=R]34#5O95)D4#EE4S(K=5-25R]W0EIG4$=74#%B=$4U>'0R M6F$Q52M/2%)3DTW46=E25,V53186CAX=VU05S`S M.'%E8V9-;##%I,W8P=6)6-U8F(WA!.WEK:VYP3D]7:'%U+WAR540O2W!M M5FUL15-H>$-X5&DT67E-6CA*,W1.=DM7;C9&<6XO3T]F;40Y05)-3EEL:60Y M8C5-6DIP3&DR6EHF(WA!.U-F2&DX83%51'A053%Y1U-5:&Y(1GDV33AC46-" M-&5F5C9&*U%/;U=D>BM5*VI#2U973F]*-&)K5D99,U=:,F\S:#A,0G9K8WAD M6D4F(WA!.VI+6$LP8V=C465B9FQM:F%P9CA!-79A-UIC<&1/=E5V;'1(545I M57IT8U-R>'`Q25-N+T):;#9J65DT;FYT*VAX345-(3&8Y3$XF(WA!.U`K M8UIR:4$O;&-V-WAF,T8U8VEB8V9!9FAB-'9$-%-$;5!R>"LX*T1K84$O=2]I M=V(X=&9I+TDW.'A:5C-I:VQV940O04Q,9C9-:#(F(WA!.U`P-6M:+S#EB,79J<#$T,"M( M2]46#$F(WA!.W%, M+T5D9E=P-CE:94A(,5!G*S$V;C)0-EI(3'@X365,;#!:675$:6QW."MR1V1( M+T%/5DEF.')D:R]25F8X8V5T8S@O5"MS*VHY63DF(WA!.TM4-GHQ+V,X=4A0 M;#)R6'9L,'9'.$QF-D=M4&#5Y+S555B]H1'EN*VYF5R]1,V]V+T%) M8C1F5R]6.4QJ2#9L94AX+WEF83EQ6FHT=DG)4-'%C4$1F2UDS>&)C M,C968T\O2F=8;#,O04I60B]W07%N,4PY1CAV.$4O=B]!3DIC=G)0<6-V:#4Q MDHF(WA!.VXT=FEI+W)C84AH945A*V@U:B\Q:68X03AV9B]! M12\U;68T5"M+8U`O0G90-UAQ368O2W!F,'8U1S5C+W)N,5%F-%(Y6#9Z=SE, M9W8F(WA!.T=V3#1E9$M5.51E=C!::"]V86PW+U4U;C=Q-"\W1E!0>E,O=TPO M:$MB+TE@O04I/ M+SAQ4B]X1F0O-$4Y8CE,+U9'.68Q=G)64'$S<7@X<65T.$@R*TAV.$%J:G%V M1S1F6'EV>5A3*T1X96IN5$EF22\F(WA!.R]+"]YF1B<5!!-'0O<3AK.2]*4"]L5'8V579F.$@O049R M.5`K:"]P=C91.50V>C9(3D]86#DS5#%/4$QJ=E50X3(O-59F.$%PB\F(WA!.T%.0S9F6#E2*W`O<$PV=%@O8VHK:5!R4#%'=%17 M=%!G-#EFF,W0G=C M4&\U4$E.8B\V1C,O5$]P+U9F,&IX-4@Y2B]O9C9Z.5)R53AU6$0F(WA!.S1/ M4%@W4'4=F:31Z>&95>G=C4$%/2#974C4F(WA!.U4R=B\R43T]/"]X;7!'26UG.FEM M86=E/@H@("`@("`@("`@("`@("`\+W)D9CIL:3X*("`@("`@("`@("`@/"]R M9&8Z06QT/@H@("`@("`@("`\+WAM<#I4:'5M8FYA:6QS/@H@("`@("`\+W)D M9CI$97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B"B`@("`@("`@("`@('AM;&YS.G-T4F5F/2)H M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O7!E+U)E&UP34TZ1&5R:79E9$9R;VT@&UP34TZ1&5R:79E9$9R;VT^"B`@("`@ M("`@(#QX;7!-33I(:7-T;W)Y/@H@("`@("`@("`@("`\7!E/2)297-O=7)C92(^ M"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#HP-#@P,3$W-#`W,C`V.#$Q.$$V1$%$03)!,T,Y-#(R0SPO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V M=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@("`@("`@("`@ M("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO<&]S M='-C7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@ M("`@(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@ M("`@("`@("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC M871I;VXO<&]S='-C&UL M;G,Z:6QL=7-T&UL;G,Z<&1F/2)H='1P.B\O;G,N M861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Y+CDP/"]P9&8Z4')O9'5C97(^"B`@("`@(#PO M#IX;7!M971A/@H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G'EZA8:'B(F*E)66 MEYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V]_CY M^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q!@`B$T%1!S)A%'$(0H$CD152 MH6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#DT9TPM+B\E5E M=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:FML;6YO9G=X>7 MI[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ M_]H`#`,!``(1`Q$`/P#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:KO\[S^=U\FO@#\F]E_' MGX[[.ZIDI'ZFPG8^[=T]D8'.[GKLED=T[@W/B<=AL+08G<^W*3%XW$4.V?++ M-+]Q-53U6D"%(+SSO[8^V.R M9.(/]RON5=ZCVG:(X-/@+(S2*S$EF8``!E``"U)-22?*F3V_R.OYE?;/\ MR7H/M#=?=NU=EX#L'JCL>FVE4Y38%'D\3MW<>$SF"@SF(JFPF7RV=JL;EZ"0 M5$%04JF@F01.J(VL$*^Z')6W\E[M!;[9)*]G<0EP)""RLK:2-0"@@X(Q49XX MZ%'MISE?\X[5//N4<:7<$P4E`0K!EU`T)8@C(.:''#/5VON,NI(Z)[\__DWD MOAO\-N__`)+X3`8_=&?ZJV0'0?YJWI^7N7KO>8D#RP15536A8D*M:4-*L":$&E:$=:MW\M3_A1!\T?DI\U M^BOCYW9LKHO*;`[AW/-LO(5.S-J[GVGN?!5M9B\]PX^=*+(4D M?W%-/1N*BG9T1X9"LJSKSK[/\M;+RS=;OMDMTMW;1ZP'975@"`5("*<@X(.# M3!&.H2Y-]VN8]YYDM=IW*.U:UN'T$HK*RD@D$$NPP1D$9'F#GK=3]XT=9&]> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW6C%\@?^%2?S"V3W[VELWK3H?XU4_6FRNQ]S[2P=)OK#=HY_?5=A MMK[@K,*:O+;BP':FURPJ[%#$J!F4-0*T3-05IEZFE<5H,9MU][>8+;=9[>SM;,64ZL! M0Y6NQ$=>B1"OI\?65$D44YCB::)5=HXV8HN.._;6=DWJZV@OXGTUP\>JE-05 MB`:>51DC-#BIX]9";'N8WG9K7=@NCZB!)--:Z2R@D5\Z'`.*C-!PZ'WV4]&O M5+W\[#^9MV1_+-Z,ZOWKU%L'9&^-_=I]B5FT:!^QTSU7L_`XK#;>JLUE*ZKQ M.V<[MG-97(5,S4T5/&E?31HIE=V8JJ-)7MGR19<[;I/;;A++%:00ASX>D.Q+ M!0`65E`XD]I/#J.O8H/$U%%`4DDA64D\`.X>?1.OY) M7\[CO_\`F0]_]F="][]6=/;7J]K]/9?M[;VZ^I*/>N`I_M\!O7K_`&97;>S. M"WCO+?LE;-6R;]2IBJX*RE6):5HVA]MO<-UFVO=(+=&2W,JM$'7X7C0J5=WK7 M74$$4I2AK7K9F]PEU,W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4:_S*?Y\'Q>_E^YO*=3 M87%U_P`@?D7CZ<-DNMMHYBCP^VMBU$\,4]'3]F;ZEILI'@LE403"9<;0T61R M*QZ341TJ2PRO*/)7M5OG-T2[A*PM-F)Q(X)9_7PTJ-0\M3,J^A8@@1GSC[H; M)RI*UA&IN]W`S&A`5/3Q'SI/GI4,WJ%!!ZU>NU/^%/'\RC?&1J)=AOTCTMB? M/(:&AVCUM'NG()2G4(H\CE.RLIO*GK:I`07EAI*1'87$:CT^YRL/8_DNU0"[ M^JN9*9+R:17Y",)0?(D_;U"E][T\XW+DVOTUM'7`2/4:?,R%ZGY@#[.@0P7_ M``HH_FX8BK^XR'R5PFZ(=41^PSO170E/26CD#NNO;/6NW:[34*-#_O7"GTE6 MLWLTE]G?;Z1:)9-&?59YZ_\`&I&'\NBV+W;Y]C:KWBN/1H8*?\9C4_SZLA^- M7_"KKO';^1Q^*^6'Q]V#V/MHN(*S=O3-3E.O][4=.=+'(3[EBRL?D"@^>,[Q>&RM-G,1BLW1"44>8QM#E:03H(YA39" MEBJX!,BLZI*(IAJ`8@'\GWB])&T4C1-\2L0?M!IUDM&ZRQK(OPL`1]A%>G+W M3J_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U`R>4QF%H:C*9G(T&)QM(J-59')U= M/04-,LDB0HU15U4D5/"KRR*H+,+LP'U(]W2-Y6"1@LYX`"I/Y#JKND:EY"%0 M<230#\ST&V+[ZZ,SE;%C<+W/U/F,C4:O!C\7V+M#(5LVA2[^*EI,Q-/)H0$F MRFP%_:V3:=TB4O+;7"H/,QN!^TCI&FZ;9*VB.Y@9SY"1"?V`]"Q[+^EW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TQ M[BW-MO:&*J,]NS<&#VO@Z1HEJLSN++4&$Q5,T\BQ0K49')5%-1PM-*P50SC4 MQ`'/MV&":XD$5NC22G@J@L3^0J>FIIH;>,RSNJ1#B6(`_::#K/@\[@]S8JBS MVV\SBMP8/)1&?'9G!Y&DRV*KX1(\1FHLC035%'51"6-E+1NPU*1]0?>I8I8) M#%,K)*O$,""/M!R.K12Q31B6%E>(\"I!!^PC!Z=?;?5^O>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z^>#_`,*C/^WE6"_\5DZM_P#>L[,]Y@>Q?_*E M/_SW2_\`'(NL2_>S_E<5_P">*+_CTG5M/_"2[_LGCY;?^)GV1_[P\_N/_O`? M\EC;_P#GF?\`X_T//8?_`))-_P#\]*?\/_`%/'52G\];_MTY\R/_#, MV3_[]SKWW('M9_RO^V_\U7_ZM2=`/W._Y43OJ@^\$>LW M^OFI?SQ_D+WWB_YI7RMV]B>Z^U\/M_;.X=D87;N"P_86Z\3A<'B8^KMD5PQ^ M)Q6.RU-04%*U=73SNL4:AYYY)&N[LQS4]KMHVF3D2PFDMK=IG1V9C&A9CXKB MI)!)-`!GR`'`=8<^YF[;HG.]]#'T^Z.Q=P="[^S]'UUW+@MX[]W'F]L46V]UR?P>@W]4T&;R5 M?0TM7UQF:R#+-51Q&J^P@JJ:-@M2X*CW!Y'V[?\`EFXBL+:%-VB0R0LD:JQ9 M,F,%0"1(`4I6FHJQ^$=)^0N==PV+F."6^N9GVN5Q',KNS*%;`>A)`,9(:M*Z M0P'$]?3:5E=5=&5T=0RLI#*RL+JRL+@J0;@CWA'PZS.XY'6KA_PJ;[<[1ZT^ M-'QJQ?7786\-AT>[.ZL\^Y1L[<&3VU4YQ,!LJIEQ%+DJ_#5%'7U./HZC)2S" MF:7[=YQ'*Z-)#"R3I[$[?8WN]WLEY#'*T=LNG6H8+J?)`-0":`5I6E16A-82 M][[^]L]FLTM)9(EDN6U:&*ZM*8!(H2!4FG"M#2H%$7_PE4[=[4[)ZI^8&'[$ M[&WOOS&[5W[U-6;:I=X[GS.YEP51N3`[W3/-BI,S65LM$F5&`HS,D;*C-`K6 MU7)5>_.WV%E?[=)9PQ1/)%*&**%U:6336@%::C3[>D_L=?WUY8[A'=S2RHDL M14.Q;3J5]5*DTKI%?LZVQ?<`]3KU\CGN'Y6?)KJY^9/'SZP*W#?-ZEW">9[NY\1IG)_4<9+'YX^5.'7U&?@?NW M&]?BE\=]V[KW%E)C49//;EW'U#L_,9W-9&<@&>ORF4 MK)9YGL-4DA/Y]X,XDL;=F8\69HD+$_,DDGKY^?>GPR_G?_`.FCM:3)]7_.3E_P"^_P#&_P"Z'^D?M#T&]SBYOV71^]C?VWBZM'B-(NK3352IS34*^E1TS=(M\_\`Y*;@ MRVU.@,Y\INXMRX+#G<.9P?7F[.RMSY/%X-:VDQIRU;28S*SRT]`*^NAA\C`+ MY)56]R/;FY_U2V6%;C=UL+:%VTAI$C4%J$T!(XT!-/ETWMO]:MYE:#:FOKB9 M5U%8VD8A:@5(!X5('Y]&PP'PQ_GAOG,.N&Z@^?N-R_\`$Z$XO(5-7VO@8*'( MK4Q-15DN;RF7H,=B$IJ@*YJ9YX8H=.MG4`D$$W,OM?X3>+<[2T>DU`$35%,C M2`2:CR`)/IT>QH M8](-L]T@H>!4R`4/Y8ZS`OGG@V>:341_^[*BHJ)9)YYY^U=]2S3S2N9)9II9,\SRRRNQ9F8DL3<^\_ALNS*`JVEL% M'_"D_P"@>L$3O.[L:F[N23_PU_\`H+JS'_AO;^>;_P`^A^9__H>[A_\`LT]@ MG^M_M=_RD;;_`+PO_0'0S_JG[F?\H^X_[VW_`$'U[_AO;^>;_P`^A^9__H>[ MA_\`LT]^_K?[7?\`*1MO^\+_`-`=>_JG[F?\H^X_[VW_`$'UN>?R(NG?F)TA M\':G:/S4&]Z/L.M[HWSN#8^`[$W+_>?=FV>KJ[!;+H\9B>- MSM?#233M)'#6J]D614&-GNKN/+FZ!^?6O+_PJ/[Q[FV5 M\YND]D[,[7[%VAM&E^)^U=TP[HF][=SW&VYFMK:VGFCMQ8*VE791J:68$T!&2%4$^@'5;7PB^$?\TC^8+L#= MG9?QS[?W5D]K[+W@VQLY+NSY%;JVM6QY]<+B\^8Z:CJLG.]12_P[,0GR`@:R M5_'L:M=%NK#3J*Y('&H..@?RURWSOS7:R7FT7#M! M')H;5<,IU4#<">%".C*;_P#Y,/\`/=V+AJK-TE7OWL""BI9:NJHM@?*>')YE M8H;F1*7#YK>NW\CE:K0+K!1QU$TGZ41F]/LDM/'6_W_`"]OGST__,4^/>%[QZK,N&R= M/4#;O9?7.3K*>JW#UKOJFI8*BOP&0EA6%3MW;:[_`+D(U1R`461*X8>A'!EJ2K>9%&.5/*?-.W\W;2NYV/:X M.F2,FK1O3*GU!XJU!J'D#4`\_L+=";KX]_R/_P"RA^^?_$S]H_\`O<9SWT3V M;_DCVG_/-%_QQ>N?V\?\E:Z_YZ9/^/MU]0W^5'_V[5^#7_BLG4O_`+R>/]X- M<^_\KKNG_/=+_P`?/6:W(O\`RIVV?\\47_'1U8'["/0KZU*O^%:/_9/'Q)_\ M3/O?_P!X>#WD!]W_`/Y+&X?\\R?\?Z@?WX_Y)-A_STO_`, M)'65G7R`$F`!0#X?(=8`R;YO,LC2R7=R9& M))/B/DDU)X^O5B&$^!_\[CWC[ M)P=?G^V8\MUAMGM3>#;JW-C,!#MNAH=P5T%--F#W&ZN>/'Q'_`.@N MMZK_`(3*?-+=_P`B/BWVCT;VIOC.[X[$^.V]\;/@\ONS.5F?; M..:ORT]3E,E#MC=&W,S3AVED2DHZBCIP(T6(-BS[W1'4 M$4*OBQGN-!0#4K(>&2&.37K)OV8YCN-WV2?;+Z5I;NTE&DLQ9O"D':*G)TLK MCC@%1@4ZV8/<)]3+U7E_-DWQO#K?^6]\QMY["W'E]H[MQ'2NXTP^YKJL3DJ<]MMKM%DMV MN5JK"JFE2`1P(J!4'!X$$8Z"7/=S<6?)^X7%J[1SK;-1E-&%:`D'B#0FA&1Q M!!Z^=%\&_D[\C\?\T?B9/3=]]Q7F^2'2N/J8:CLG=];1UV-RW8NW<5E\7D:" MMR]10Y+%9?%UDU+5TL\ M\"NLYNB'?S/-G]\[_P#@/\G=F_&3^\K=W[@Z]%#LJ#9N7."W37+_`!_"3;FQ M>!R:U5%)!DLKL^+(4T:1RQRSF7Q(=;K[%?(]SM5IS98W.]Z/W6DU7UC4H[6T MEA0X#Z3PH*5/#H+\Z6^Z77*U[;[+K_>3Q430=+'N&H*:C)34.-36@Z^?%_LF M?\[#_GR?\P/_`,Y.Y?\`ZK]Y=?UD]L_^4K:/VP_YNL4?ZN^Y'_*-NO[)O\_1 M5>YLQ\[?CMN^/8'>NZOD[U+O:;#T6X(MK;]WCV/MO.28/(SUE-095,=DLO!4 M-05=1CYTCDTZ6:)@#P?9]ML?*N\6_P!7M4=C<6P8KJC2-EU"A(J!Q%1CY]$6 MXRP7.D-I=Y%;2:@&A/`T/[.A!Z1V!_,W^2FW\MNKH"@^8G<6V M\#F#M_,YSKS-=I[GQF+S@HJ7)'%5M7C,E/#3UXH*Z&;QL0WCE5K6(]I-SN^2 M-EF6WW<[=;3.NH+(L2DK4BH!'"H(K\NE>VVO.F\Q-/M0W"XA5M):,RL`U`:$ M@\:$'\^CC=`?#;^>#%WEU#/B>M/F_M+(4O8^SJV#<^\,AV3MW:F`^RSU#5S9 M7<>8W+7QX&DPM%!"SU(JM<4L0:,QR:A&P M6Z]R;#^#?S-WQLW-9#;6[]F?%#Y$[KVKN+$5#TF5P&Y-N]0;PR^#S6,JH[24 MV0Q63HXIX9%Y22,$?3WB3RI;PW?-&VVMRH>WDO[='4Y#*TR!E(\P02#\NLJN M:)YK7EG<;FW8I<1V-PRL,%66)RI!\B"`1U\Q+XQ_*#Y)X_Y*=`Y&E[_[G6KB M[JZQ?7+V;O.JCF$N]L*E1#5T]5F9J>MI:N*1HYX9D>*>-V2161F!S?WO8]E? M9;M&M+;3]-+_`*$@_`W"@J"/(C(.1UA=LN][PF\VKK=W.KZF/_1'/XQQJ<@^ M8.#P/7UG/>`/6=W26WQ7U>+V5O#)T$S4U?CMK;@KZ*H549H*NCQ-744TRK(K MQLT4T:L`P(-N01[?M462YC1Q5&D4'["17IBY9DMI'0T8(Q'V@'KY%J_*OY0) MFUW*GR-[V3<*949Q,TO;>_ER:YE:O[]42AM8D]5[^^A'[AV M,Q>`;.U\'3IT^%'332E*:>%,4ZP(_?F]^+XWUEUXNK57Q7K6M:UU<:YKU]=+ M8]?5Y396S\G7S-4U^1VMM^OK:AE16GJZS$TE14S,L:I&K2S2,Q"@`7X`'OGO M=(L=S(B"B+(P'V`FG6>]LS/;1NYJQ12?M('2I]L=/]56_P`Y+YU5WP!^#V^^ MU-HST\7;F^,E0]1],M41QU$>/WUNZARE5+NB2FD)64;+VMA\CE81)'+3RUU+ M303*8YB/8\]N.5DYMYHBL+@']WQ*99OFB$#37^FQ53P(4L1D=`?W#YG;E7EJ M6^MR/KY6$4/R=P3JI_04,P\BP`.#U\R79&S^Q_D)V]MG8^VXLKOGM;N7?^-P M&+%;53UV7W/O;?.=CI4JLGD:IIIYJC(Y?(F:JJIF-M3RR-8,?>;EU\W;<$MH=4M]<2A14U+.[4J3\R:DG[ M3U]+;^75_)M^)WP.ZVVU#4]?;)[?^0+T%-5;[[SWKMC'Y[,SY^5#)6T77U/G MH*]=A;3HI)#!3Q4*P555#&DE;+/-RN%/./N/O_-=ZY6:6WVBI"0(Q4:?(R:: M>(YXDM4`U"@#K,CE'V\V+E>S0-%'<;K2KS.H8ZO,1ZJZ%'``4)&6)/5FO9'4 MW5O<>WJC:7;?6^Q>SMKU<-33U&WM_P"T\%N_#20UD:Q52''9^AKZ5?/&@#$* M"=(YX'L$66X7^VS"XV^:6"<$=T;LAQPRI!Z&=Y86.X0F"_ABF@(/:ZJXSQPP M(ZU7?F9_PF,V1NCOWJ[LCX;9?";`ZFS?8NVSWETYO/*Y7(8_:FTGS=#-N/<7 M5.0K8\I6Y*G;%BHUX#(U*JDA44M2L)%-#/'+?O?=0;3/9XP?S%[+VT^ZP7G+S+%8-,OC0N20JU&IHB:DXKV,?]*: M=HVX_>/G4]]?/E_X4D]]=W[9_F2Y/:.V>W^S-L;6V_TMU<,-MS;6^-R;?PF/ M?*T^7RF3G@QF'R5%1_=U]=4L\TS(9I`$5F*QHJY=>R^T[7/R6MQ/;P/.]S+J M9D5F-"`,D$T`&!P_:>L4?>'=-RAYQ:WAN)D@2VCHJNR@5J3@$"I/$\?V#HGG MPB^$?\TC^8+L#=G9?QS[?W5D]K[+W@VQLY+NSY%;JVM6QY]<+B\^8Z:CJLG. M]12_P[,0GR`@:R5_'L1\S\S\B\HW<=EO-O&L\L>M=%NK#3J*Y('&H..@_P`M MY?Y5W\]/XZ;;RO959)W9NK!;1 MIVRF1S/3?R-R6],_C*2&G,U3D*/:V$WE!OVLBHH]7F>CQTQB56=K1C7[+=MY M\]K-YF6R7Z6.60T"S6X12?0LR>&*^56%>'''1AN/(_N;M$+7C?4O%&*DPW!= M@/4*'UFGG133CPZ7O\M7_A0W\IOCOV/M/8_RV[!W)\B/CGF54E53MBD(SH9!VI7@&0+0GN#`4"KDWW9WS:+R.VWZ5[O:&8!B_=+&# MC6K_`!/3B5.IHJ_'UT$= M51UM)4PL\512U5-*LD;J2KHP(-C[Q!='CH/662.DB"2, M@HP!!'`@Y!'R/5$O\[+^<31?RX]EX/JSJ*DP^Z/E9VE@Y\UMNES,:5VW>J]E M"MEQ@[!W5BQ-%+EJ_+U])54N"Q]Q!/44=145+>&F6FK)4]LO;INF[^Y,Q@UCRV]>SNX]YY6AZJZQILF]0 MF-II)(:3(X[;JY*9)4H,)M[%2U#1I+)#1BG@J)(LDMTW;DSVSVQ"T4=M&^$B MA0&64CB>(+4QJ>1@*T!:I`..^V;7SA[C[DP$DEQ(N7DE M)"T!(LTWS_PE,^:N!VC+F=E=X_'K?VZJ6EFJ)]F&KWQM4U\D2ADH<#N'*[8G MQE56U!N$->N,IP;:Y5'(!-K[]10$TUT1J?-E#5`_TNH_+H9W7L M9S'%;^);7-I+.!\%76OR5BM"?]-I'SZK?^.?\Q#^8Q_*>[KR?5U;N3>^,I^N M-P)@NR?B]W)69'.[%>.G6.6;'4.*K*NJ.T)J^@J(JFBS&WIZ854+03"2KHV$ MXML M557#5YK8&^,6L46Z-B[@:%(1_$L'62@QRF.):VBEIZN-1#41DX=LN>6^8++F?9XMWL32.0492:E''Q(WS M4^>*@AA@CJMO_A1=V)OSK7^63OO+]>;RW+L?+Y7M#JC;]?F-IYFOP&7GPE;N M"2KK<8,IBYZ:OAI*V;'Q"9(Y%$T:F-[QLRL-/9RSM+WG>*.\C26-8)6`G$9Z!WNY=W5GR9+):2/%(T\2DJ2IH6J144-#05]>'#K57_`)`/ MR![VSO\`->^,^TL[W/VIG=K;NQ_>&*W/MS.;_P!U9C"9['8[H#M#=5!1Y7%Y M+*U5%604>Y-NT%=$'0Z*FDBD%F0'W/'NUM&U1<@WMQ%;0)/&8"K+&H929XE) M!`!%59E/R)'4'^U6Z[I+SU902W,[02"8,K.Q5@()&`()(-&56'S`/7T?/>&G M67W57?\`.FWKN_KW^5Y\OMV;$W/G=G;HH-A8"BH=Q;:RE9A[$V;M_, M1463Q\T%92?Q'"Y2HII#&ZL89F6_/L<^VEM;WG/.W6]TB20&5B58!E)6-V%0 M<&C`$?,=`GW&N;BTY*W">U=HYQ$H#*2"-4B*:$9%02/L/6F9_P`)_OD/WUF? MYK7QLV;F^Z.TL]M/>N-[MQ&Z]MY[?FYLW@\_CL7T'V?NW&TV2QF5R=71SK0[ MEVW0UL3%-:3TR$$<@Y(^[>S[5'R%>W,5M`EQ$T)1EC564F>)"00`;.WEN9V@D$P96=F5@()'%021AE4CYCK?U^6FX\[L_XJ_)G=NU\ MK6X+N"MQV0I8YHG'*R("/I[Q M,Y?ABN-^L;>=0\$EY"K*<@JTB@@_(@T/65._32V^QWL\#%9DM)F5AQ#"-B"/ MF"*CKY2>U>Z_D[OC=FV]H8;OCN*;.[OW%A]MXH5?;&]X(9>T^V;':V[W$EI;"*-"QI$G!14T>'6#$&Y;UA%#-+'V/+4O%%)(E-!\LLTLU0Z(66"%J MG)T].LLI&E3)(B`GU,HN1%0]TO:TD`PT'K]*/\@ZE`^V7N:!435/_/4?\_5> M/:^X/YNG\KGMC$8_LOLSY,=#[SR4$N1P%7/VEE=W;!WUC\?4I'.U+5TNX=U] M:;]HJ*9HFJ:*?[LTIEB^X@C9T!&%A%[>\];>SV4%E=VRFC#P@DB$CS!5)(R< MT84K0T)H>@E?2\_37MK<$54^*71P#Y$,T;@8J#6E14"HZW.?Y'O\W6 MK_F/==[KZZ[CI,+@_E!TYC\=D=S-@:88_!]G;$JY(,72]C8G%!V3#9>CS3K2 M9RAA`HX:BII9Z;1%5_:4F-ONA[>KR9>1WFW%FV.Y)"ZC5HG&3&3^(%ZZ[9?559T9A.PNP=U]6=/?(G!9OI MC,=U]V;GWH&I,]FZ+[RGH\524-'6P4WW`G$O*D-OMUG;[?"8XHKC9)KZ:8R3 M0AY1.T<:2S6[+,(853*(U"69V4M2@Y-F=+;0R'8?4/R$W+U)TY+3]4]3=[45?M7);6W9%@:6FIZN/)T4 M>2A7*0%RWS[%87EKN=D`S3[1':,LCM)(RO,XCFMUEF_5E@(998C(2058H?#/ M5^19;ZTNMMO:JL&[/=*T:+&BLD*&2*=HHOTHIP5:*4(`#J4.-8ZVI/<$=3AU M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SP?^%1G_`&\JP7_BLG5O M_O6=F>\P/8O_`)4I_P#GNE_XY%UB7[V?\KBO_/%%_P`>DZMI_P"$EW_9/'RV M_P#$S[(_]X>?W'_W@/\`DL;?_P`\S_\`'^AY[#_\DF__`.>E/^.=;:OO'_J> M.JE/YZW_`&Z<^9'_`(9FR?\`W[G7ON0/:S_E?]M_YJO_`-6I.@'[G?\`*B;C M_P`TT_ZNQ]:%/\F?_MZ-\*/_`!-&+_\`=1F/>5WN1_RHNY_\\Q_PCK%SV[_Y M7;;?^>D?X#U]4'W@CUF_U\O+^>K_`-O8OF3_`.'ILO\`]]+U][SE]K/^5`VW M_FD__5V3K"GW._Y7OL?EI\5>E.S* M%X(63'T/:>.ZRV51=MXB)Q"B?<9#*5M'N"2[N3)G7`LJ!17V_P"9?WW%?[;. MU;[;[^:,^IB,KF(_8`#&/D@ZWSYRY^YI;'<8%I97]C#(/02B-!*/S)#_`.WZ MW8_Y#WS7/S+^`NP!N;--E.W.@6@Z1[--95+/ELB-LXZE;8>[ZS7:KJ%W1LF2 ME6:LEU&JRM'7>MW1S[QF]U>6?ZM\V3>`NG;[O]>*@P-1/B(/+M>M`."E/4=9 M(>U_,G]8N58O&;5?VOZ,E3DZ0-#GS[DI4GBP;T/597_"M'_LGCXD_P#B9][_ M`/O#P>QM]W__`)+&X?\`/,G_`!_H&>_'_))L/^>E_P#CG2+_`.$C_P#S+SYO M_P#AY]%_^Z/L_P!J?O!?[F;7_P`TI_\`CT72;V%_W$W+_FI#_P`=DZW"?>.W M60/7QN^Q_P#F8>_/_#SW1_[O*[WT!'.?\`RN&[?]+*Z_ZOOUG1R?\`\JEM?_2N MMO\`JRG1S_8:Z$76F'_PKN_[I\?^78?_`#M7O)/[O7_+7_ZA?^UGK';W\_Y9 M/_45_P!J_19/^$GG_99GR-_\5CG_`/?J=>>SOW]_Y5NS_P">[_K%)T2^Q7_* MQ7G_`#Q?]98^M]?WBCUE'T"_R0_[)W[Z_P#$+]I?^\/G?9GLO_)8M/\`GIB_ MX^O1=O'_`"2;K_GFE_XXW7Q\/?1+KG]U]G?WS:ZZ)=>]^Z]U[W[KW7S]?^%6 MO_;P[IK_`,4PZ\_]_A\BO>6_L)_RI]S_`-+*3_JQ;]8I^^?_`"MMO_TKH_\` MJ]<=6T_\)//^R-?D=_XLW-_[ZOK[W'_O[_RLEG_SP_\`663H>^Q7_*NWG_/; M_P!8H^MJ'W!'4W]:D_\`PJ1^#^T-P])[,^=.SMOX_%]C==[JP'7/;^4H*6*D MFW?UUNT/BMHYC/S1K_N0R^RMVQ4>.I)&7S/0YAHY)&CI::-,@?8OFBXAW.7E M:Y6K>;;8^9[=`MY"ZQRD"FN-L( M6]2C44>='H310.JA_P#A,W\FE*C)RQ;&^46QMQ[.RF+EE9,<-\; M$P^5[!V+GW12`X\H'=9;]?' MO^1__90_?/\`XF?M'_WN,Y[Z)[-_R1[3_GFB_P".+US^WC_DK77_`#TR?\?; MKZ+_`/+.^>7P;V'_`"^OAOLO?/S-^*&S-X[7^._6&$W+M/=GR)ZAV[N7;N9Q M^V*&GK\1G<%F-X4>4Q.3HIT*34]1%'+&X(901;WASSMRIS1=\W;E2LKI;S,K*6-"K!""#Y$&AZRYY-YHY9M>5-NMKG<;&.X2TC#*UQ$K*0HJ&4 MN""/,$5Z/%_PX_\`R\?^\\_AA_Z5'T?_`/9S["_]3.BV=N#,U.-HJBI!C26941W]()/'N'=R_^*8=A_\`O\/CK[$7OW_RI]M_TLH_^K%QT'O8S_E; M;C_I72?]7K?KZ!7O$CK*SKXQ'OI+USMZ^P?\;_\`LG?H7_Q"_5O_`+P^"]\[ M=Z_Y+%W_`,],O_'VZZ`[/_R2;7_GFB_XXO0T>RSHQZ][]U[KWOW7NM+[_A6- M\F9#/\9?A]AJ]EB2+,?(??\`1)(A6621\IU[U?J"-Y%:!8]TO(C@*WDA87(N M,D_8'9!2^YBD&<6\9_9)+_UB_GUCK[[;R:V7+\9QF>0?MCC_`.LO\NJ],!_+ MK6I_X3O[O^5TF`MV34?)7&]\8[(?:R1Y>7I+;%94_'M\&8YF4C&)G,YE=QM* M%'EI8HG6Z*"PPFYQT^\$>P!_\2%D8"*X\9@+C5]NE5CIY$D=!.+E&OM+)OI3 M_'#>"<'S\%3X%/LU,TGS`!Z"O_A.M\FT^/7\RCKS:^7KDH]H?)+;^;Z'S1G8 MF"/<&=DH]P]\6R'>.2YIXQ6XLG6=?\` M2K59/R$;,Q_THZ0^T>]#:><88)#2WO$,!_TS4:/\RZJH_P!,>OI0>\+NLQ.J MR/YS/_;KCYK_`/B&,E_[N,-[&_MM_P`KUMG_`#TC_`>@7[B?\J3N7_/,?\(Z M^:U\*/\`LLKXD_\`BS?0O_OU-J>\TN9O^5;W#_GAG_ZM/UAURW_RL5A_SVP? M]75Z^NY[Y[=9\]>]^Z]U[W[KW7SP?^%1G_;RK!?^*R=6_P#O6=F>\P/8O_E2 MG_Y[I?\`CD76)?O9_P`KBO\`SQ1?\>DZN=_X2>?]D:_([_Q9N;_WU?7WN-O? MW_E9+/\`YX?^LLG4B^Q7_*NWG_/;_P!8H^MJ'W!'4W]$P_F/_P#;O'YY_P#B MF'RC_P#?'[Y]B7DS_E<-I_Z65K_U?3H.\X?\JENG_2NN?^K+]?*^^.'_`&4/ MT-_XF?J[_P![C!^\[MY_Y(]W_P`\TO\`QQNL(-G_`.2M:_\`/3'_`,?7K["' MOG9UT!Z1?9'_`#+O?O\`X9>Z?_='7>U-E_N9%_S57_CPZ37G^XDO_--O^.GK MXWGOHYUSVZ^R'UO_`,R[V%_X9>UO_='0^^<=[_N9+_S5;_CQZZ$V?^XD7_-- M?^.CI:>TW2GK2/\`^%:_:-;5]B?#KI6&H\>/P.R^S>T\G/N_6*K9[CN9'>\L40/H$5G:GVZUK]@Z MQM]^;UFN]OVX'L6.20CU+,JBOV:&I]IZKX_X32=0XKM#^9[MK<65I8JR/HWI MWL[MZBAG\;0KE3_=_JS'530R$">6@J>T140V#-%/$DHL8PP%WO7N,ECR.\,9 MH;JYBA/V=TI'Y^%0^H)'GT$_9O;TO>=$FD%1;6\DH^WMB!_+Q*CT(!\NOH[^ M\->LONO>_=>Z][]U[KWOW7NOG&_\*8_^WH^Z_P#Q#'3_`/[IZ_WF5[)_\J+' M_P`],W^$=8A>\O\`RNTG_/-%_@/5Z/\`PD\_[(U^1W_BSW_K%'UM0^X(ZF_KY*G\Q?;NSMI?/GYG; M9Z_IZ&BV;@OD[W;C,#CL6L*8O%4E+V'GXWP^+BITC@AQN(J0]-3QH-,<,2J" M0+GH#R=-VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM`!;K>S!0.` M`D;`^0.!\AU]+_\`E?Y#,Y7^7)\&Z[/3551DI?BOT>C3UD?CJ9Z.GZ^P5-BI MI"4C:?R8J&$K,UVG4B1FE)\=#]UMK;U/53Q)Z35U$SDL[N[9G7[>I:?=>`FR M$D2J7GP^PJK$8Q5;U1QT2JWJU>\2/=#>9=YYVO79B8;>4VZ#R40G0U/MD#M_ MMNLK/;39X]GY,LU4`37$8G<^9,HU+7[$*+^75MWN/NA[UI.?\*P_C7@\1NCX MS?++!8U*3+;QI=R])]B5D%.8XLE4;:A@W7US65,D2"*7*?PVNSE,\DI\KTM) M3HI*063)GV"WJ62"^V"5JQQE9HQ7AJ[)`/E4(<8J2>)ZQO\`?79XHY[+?8EI M)(&AD/KI[HR?G0N,YH`.`Z2O_"3SY#93%=R?)7XLY#(.^W=Z=?8OO#;./G=1 M3T&Y]BYW$;+W.V/%U)K=QX/>F/:=3J+185"ND(VI1[^[/')MMEOJ#]:*8P,? M574NM?DK(U/FY]>F/8K=GCW&\V-S^C)$)E'HR,$:GS976OR0=7#_`/"F3_MU MSNK_`,31T_\`^[?(>XZ]D_\`E>H_^>:;_`.I!]Y?^5)D_P">F+_">M2S_A/; M_P!O?OB+_P"5\_\`@8>ZO>0'N]_T[O_Z=WN'_-C_`+28 M>L;?:?\`Y7^P_P";_P#VC3=?0]^;'_9&?RW_`/%8^^O_`'U>Z_>'_+/_`"LF MW_\`/=!_U=3K+3F3_E7;_P#YXI_^K3=?*+^.'_90_0W_`(F?J[_WN,'[SWWG M_DCW?_/-+_QQNL&-G_Y*UK_STQ_\?7K["'OG9UT!ZU_?^%+?6>U-Z?RP-[;U MS5'CVW'T_P!G=4[MV9D)T1,C3UVX]X8[KG,T&/J!"\S05^"WC-+/3ZTBD^U2 M1M301CW+?LI?7%MSS%:Q$^#9ZBKWDLH+GDJ2YD` M\:WFB9#YU9Q&0/M5R2.&`?(=:KO_``G#WEF]L?S8NCL)BC4"A[%V5W=LWH/\`:"XD@Y[MHDKIFCF1OL$329_VR+^=.MX7Y&?R^*7M+N:@ M^1?3?9>-Z:[>.?Z_W7NZGW=UE1]S=1]A;QZEHZ[&=4]B[IZYDW=UYF:;M#K; M$9.>@Q>-AJ[E*DDG)7=^4UOMQ&[[=,+?<-<;-KC$T4CQ`B*1H]<9$D8) M57613I[6#``#/\3?Y>.V/CQVCO/Y`[ZWS%VUWGO.HWK)3Y+";'H>J.HNMH.R M<_0;I[*/4?3V/SV[8MIYCLW<6*I*S<65K]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U\\'_A49_P!O*L%_XK)U;_[UG9GO,#V+_P"5*?\`Y[I? M^.1=8E^]G_*XK_SQ1?\`'I.K:?\`A)=_V3Q\MO\`Q,^R/_>'G]Q_]X#_`)+& MW_\`/,__`!_H>>P__))O_P#GI3_CG6VK[Q_ZGCJI3^>M_P!NG/F1_P"&9LG_ M`-^YU[[D#VL_Y7_;?^:K_P#5J3H!^YW_`"HFX_\`--/^KL?6A3_)G_[>C?"C M_P`31B__`'49CWE=[D?\J+N?_/,?\(ZQ<]N_^5VVW_GI'^`]?5!]X(]9O]?+ MR_GJ_P#;V+YD_P#AZ;+_`/?2]?>\Y?:S_E0-M_YI/_U=DZPI]SO^5[W'_FHG M_5J/K;N^>'PL'S1_D;=+8?;V)&1[8Z6^+W1/=_5!A@:;(UF7V7TW@9=T;5HE MA*3U,N\MD39"CIZ>_CDR9HY&4F);8]HZ@W/)$2L'EG]_P+6_L"9EQDQT_67[-(#_`#,8'GU#'M)S M)^X^:$LYFI8WP$3>@DK^DWVZCH^0D)\NKMO^%:/_`&3Q\2?_`!,^]_\`WAX/ M<8_=_P#^2QN'_/,G_'^I)]^/^238?\]+_P#'.D7_`,)'_P#F7GS?_P##SZ+_ M`/='V?[4_>"_W,VO_FE/_P`>BZ3>PO\`N)N7_-2'_CLG6X3[QVZR!Z^-WV/_ M`,S#WY_X>>Z/_=Y7>^CEE_N'%_S27_CHZYZWG^Y2?W>O\`EK_]0O\`VL]8[>_G_+)_ MZBO^U?HLG_"3S_LLSY&_^*QS_P#OU.O/9W[^_P#*MV?_`#W?]8I.B7V*_P"5 MBO/^>+_K+'UOK^\4>LH^@7^2'_9._?7_`(A?M+_WA\[[,]E_Y+%I_P`],7_' MUZ+MX_Y)-U_SS2_\<;KX^'OHEUS^ZN>_Z"$OYOW_`'EU_P"P#^,/_P!I7W&W M^M#[=_\`1O\`^J]S_P!;NI$_UV.?_P#E/_ZH6W_6GKM?^%"?\WU65C\N`X!! M*-T'\8PK`&Y5BG2ZO9OH;$'^A]Z_UH?;O_HW_P#5>Y_ZW=>_UV.?_P#E/_ZH M6W_6GKZ(OPW[)[$[C^)WQN[8['#5;R56'BJ*JJ:5:21F>F#^,FZ^\/N8[*SVW?[W;]O;78PW4B(:ZJJKD#( MP<"E?/CUEMR]>7>X;%9W]^NB]FMHW<4I1F4$X.1DUIY<.M(C_A5K_P!O#NFO M_%,.O/\`W^'R*]Y.^PG_`"I]S_TLI/\`JQ;]8U^^?_*VV_\`TKH_^KUQU;3_ M`,)//^R-?D=_XLW-_P"^KZ^]Q_[^_P#*R6?_`#P_]99.A[[%?\J[>?\`/;_U MBCZVH?<$=3?U5!_/)P5-N+^5'\R\?5M2)%3[`VSG4-:H:$U.U^S=C[FHE0,0 M!5O68B-:<_43E".1['WM=*T//VVNM:F9EQZ-$ZG\J'/RKT!?OJ\=_,P^#M113-!-)\D>LZ!W548M293/4^,KX;. MK+IJ:"LDC)M3FP&X:&+(8V2NQTM$\E%5-33*7C8DH>/8$W/W;Y.VC<)MLO'N!=0 M2,CTB)&I30T-;MUL(=RM$@-K/&KK60`Z6%144P>A1_P"@9S^: M/_SRG3'_`*.##_\`U![0_P"O9R+_`+\N?^<)_P`_2W_6:YV_WW;?\Y1_FZ(Y M\X?Y4_RX_EZ[5V-O+Y'8?8N,PG8>X,CMG;% MB6.9RJZ7#9`J:TX8ZM+_`.$I7_;P[N7_`,4P[#_]_A\=?8$]^_\`E3[;_I91 M_P#5BXZ&WL9_RMMQ_P!*Z3_J];]?0*]XD=96=?&(]])>N=O5PFV_Y^/\V;:. MWO^@A+^;]_WEU_[`/XP_P#VE?;?^M#[=_\`1O\` M^J]S_P!;NG/]=CG_`/Y3_P#JA;?]:>M_/^6CW=VW\D/@E\:>\>]:6"F[5[&Z M_&A3=6W:*DR0^W2.DD^[\E.D<#1HN)G.N MU[?LO-5[M>U$FPAFTK5M5.T%EU>>EB5SD4H234]94^,_LZ2;\[.1=KBY7Y'M M(;FB%+)R];+RN.6# M3Z;Z+Z-<\>OE+TE3OSH+M^FK(#+MGL_I7LB&IA+!9)]O[\Z MXW.LL99?T22XG<.&%Q]"8_>>K+:;MMQ4]]C9XR?72Q`(^3#(^1ZS MUVC<8=WVNWW2#^RN(4D`]-2@D'Y@X/S'1+OYS/\`VZX^:_\`XAC)?^[C#>Q+ M[;?\KUMG_/2/\!Z#GN)_RI.Y?\\Q_P`(Z^:U\*/^RROB3_XLWT+_`._4VI[S M2YF_Y5O&?_JT_6'7+?\`RL5A_P`]L'_5U>OKN>^>W6?/7O?NO=>]^Z]U M\\'_`(5&?]O*L%_XK)U;_P"]9V9[S`]B_P#E2G_Y[I?^.1=8E^]G_*XK_P`\ M47_'I.KG?^$GG_9&OR._\6;F_P#?5]?>XV]_?^5DL_\`GA_ZRR=2+[%?\J[> M?\]O_6*/K:A]P1U-_1,/YC__`&[Q^>?_`(IA\H__`'Q^^?8EY,_Y7#:?^EE: M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\` M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L` M_C#_`/:5]QW_`*T/MW_T;_\`JO<_];NI`_UV.?\`_E/_`.J%M_UIZA9+_A0% M_-RR^.K\3D?EI]QC\I156.KJ?_0/\9HO/1UL$E-4P^6#IF*:+RP2LNI&5EO< M$'GW9/:3V]C<2)M]'4@C]>YXC(_T;JK^ZO/LB&-[^J,"#^A;\#Q_T'JF[W(_ M4>]?9#ZW_P"9=["_\,O:W_NCH??..]_W,E_YJM_QX]=";/\`W$B_YIK_`,=' M2T]INE/6A1_PK#_[+,^.7_BL<'_OU.P_>5WL%_RK=Y_SW?\`6*/K%SWU_P"5 MBL_^>+_K+)TW_P#"4&LQZ?.'Y`8^1D&5J?BGFJRB0PNTC8^A[=ZFAR;)4",Q MQ(M3D*0,A=6D)!`8(2M_?Q7/*]HX_LQ?J#]IBEI_('_4>J>Q3(.9;M#_`&AL M21]@EBK_`(1_J'6_/[Q.ZRFZ][]U[K5@W_\`\*KOBYM#?^Z]I87XV=W[IP.V MMRY/`4^ZCFME8.7-T^)KI*"?+TN`JJRJGHZ>JD@>2GBGG29HBAE$+EHTG>T] MAM]N+2.XEO;6.5T#:=+MIJ*T+`"M/,@4KPJ,F$+OWRV2WNI(([.Y>)'*ZJHM M:&E0I)I7R!-:<:'`V9>KNP,/VSUGUUVIMVFR%'M_LS8NT>P,'29>*G@RM+A] MY[?Q^X\939.&DJ:REAR$%%DD698YI8UD!"NPLQA*^M)-OOIK"8@S02O&Q'`E M&*DBH!I48J!CRZF6RNX[^RAOH01%-$DB@\0'4,*TJ*T.\O_*[2?\\T7^`]75?\)U]J2Y%,1'N;<5!TMLBJPNWI,M+#418M,UDH MHJ8U#1NL`DUE2%L8S]]$AEYMV^.X?P[=K50STKI4S.&:GGI%33SI3J1_9-YH M^5=PDMT\2=;IBJUIJ80H0M?*IH*^759G>?\`PJ4^;^]-HY[9'7/4'3W0VY*^ M"NP]=O6GI]T[OWGMJ5EDIIIMN46Y:^EV]B<[1S`@/D,=D4C8']D.`RC;:_8K ME>VN$NKRXN;N$$$)541O/N*@L5/]%E^VG0,W/WMYEN;=K:SM[>UF((+]SNOE MVAB%##^DK?9T4_\`EQ_R2OEU\^^P-L=E=K;7WKU1\;L]E:#>&].Y>PXZS#[I M[)P&8GAS59-U;0[A@FS>\\KO"DJFD@S[T\N%0R-/)4S2!:>80YO+W*=H] ME8217&](I1(8Z%8V':/%*]J!",QU#XH%`R"+E#VVW_FJ[2\ODD@V=F#O-)4- M(IR?"#9 MV_CJ?$X7$T4;,[1TF.QM)%#&I)(1`+^\,+B>:ZG>YN&+W$CEF8\69B2Q/S)) M)ZS!@@BMH$MK=0D$:!54<`JB@`^0``Z^-E7UU7E*^MR=?,U379&KJ:ZMJ&5% M:>KJYGJ*F9EC5(U:6:1F(4`"_``]]'D18T"(*(H`'V#AUSS=F=B[FK$U/VGK MZ]_Q2Q,.`^+GQLP5-)+-3X7H+IW$T\T^CS2PX[KO;M'%)-XU1/*Z0@MI`%SP M![YY;_(9=]O96P6NYC^V1CUGYL48BV2SB&0MK$/V1J.A]]E/1KUK%?\`"K>D MIG_E]]*5SP1-64WS'V+205)0&:&FK>D^_IJN".2VI8JB6@A9P.&,2D_0>YO] MA&8G_A-?G)L M3_-4ZRH(D9DW-UAW/@ZEA,\0CAI]CUNY%=D52*E34;>C70U@"P>]U`,O^],0 MDY#G<\4GA8?[V%_+XNHF]G93'SQ"HX/!,O\`Q@M_S[UM"_\`"F3_`+=<[J_\ M31T__P"[?(>X-]D_^5ZC_P">:;_`.IK]Y?\`E29/^>F+_">M2S_A/;_V]^^( MO_E?/_@8>ZO>0'N]_P!.[W#_`)L?]I,/4#^T_P#RO]A_S?\`^T:;KZ;/O"/K M,[JI3^>M_P!NG/F1_P"&9LG_`-^YU[[D#VL_Y7_;?^:K_P#5J3H!^YW_`"HF MX_\`--/^KL?6DC_PGM_[>_?$7_ROG_P,/=7O)SW>_P"G=[A_S8_[28>L;?:? M_E?[#_F__P!HTW7T/?FQ_P!D9_+?_P`5C[Z_]]7NOWA_RS_RLFW_`//=!_U= M3K+3F3_E7;__`)XI_P#JTW7RB_CA_P!E#]#?^)GZN_\`>XP?O/?>?^2/=_\` M/-+_`,<;K!C9_P#DK6O_`#TQ_P#'UZ^EM\F?YUG\NWXD=P;HZ'[F[ER^/[/V M5#B7W5@-N=;]@;L@PE5FL329['XNJS6#V[5X23)OA\A33R115$G@\ZQRE)5D MC3"G9/;/G'F#;H]UVVV5K&4G0S21IJ"DJ2%9@U*@BI&:5&*$YD;S[C\I;#N# M[7N-PPO8P-2K'(U"0&`)52*T(-`<5HV]=\4]#AL_V/G,)3UM+MW$8S;5#691\1L[$S5TEV/M?<\I73[UO4D;[FT91$2I6-6(+$L0*N::<"BBOT-G[DZ[Z:R62I7I!O??6YJB#$[MW#M\S+KKMO[.VW25V,J*A%$$V M0R1BBE:2CJHT)??/FJTCVZ/E2U<->R2+),`:Z$7**WHSL58#B%6I%&4DX]D^ M6+I]P?FBY0K91QM'"3C6[8=E]5105)X%FH#56'6\A[Q>ZR7Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^>E_PJ9Q59C_YD&RZVI11 M3YSXJ]:9''NK:M=/3]@]O8>77P`DJUF+E]/)T:6_M#WE[[$R*_)DJCBM_(#_ M`,XX3_@(ZQ.][HV3G"-CP:QC(_YR2C_".K5/^$ED\+?'_P"75,LT35$7<6PI MY:<2(9HH:C95;'3S21`ZTBG>FD5&(`8QL!?2;`/[P`/[VVYJ8^FD_P"/C_.. MAQ[#D?NJ_'G]0G_'#_FZVV?>/W4\]5)_SV&5/Y3?S(+,J@[.V.H+$`%G[>Z\ M1%N;>IW8`#\DV]R![5_\K_MO_-1_^K,G0#]SO^5$W'_FFG_5V/K0S_DMT557 M_P`TOX5P4<#U$T?;T-:\<8!9:7&[W*LW.^VA14_45_(*Q/[`.OJ<>\$NLW>OEY?SU?^WL7 MS)_\/39?_OI>OO>U/>&W,W_*R;A_SW3_]77ZR\Y;_`.5=L/\`GB@_ MZM+U\Y+^<[\.*WX'_P`P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&` MPDM$4.+/76^*+(8JC19#4QT-'23L09D)S(]MN8UYKY1@FN2'O85\"<'-60`: MFKQ\1"K'%-18>76(?N)R\W*_-&X91YT"GSZLM_G M$?,>B^=7\IS^7!WO+74]3OF3LS>NQ^WZ2`)&^-[9V5L*AQ6[S+31`1T<6XF$ M&;I(06\>/RE.";W`!7MSRXW*W/\`O.U`$6O@(\)]8GD)3/GIRA/\2GH9>X/, M*\S\B;/NA(-SXSI*/25$`?[-6'`_A8='3_X2/_\`,O/F_P#^'GT7_P"Z/L_V M&?O!?[F;7_S2G_X]%T(_87_<3\D_N]?\M?_J%_[6>L=O?S_ED_]17_`&K]%D_X2>?] MEF?(W_Q6.?\`]^IUY[._?W_E6[/_`)[O^L4G1+[%?\K%>?\`/%_UECZWU_>* M/64?0+_)#_LG?OK_`,0OVE_[P^=]F>R_\EBT_P">F+_CZ]%V\?\`))NO^>:7 M_CC=?'P]]$NN?W7V=_?-KKHEU[W[KW7O?NO=?/U_X5:_]O#NFO\`Q3#KS_W^ M'R*]Y;^PG_*GW/\`TLI/^K%OUBG[Y_\`*VV__2NC_P"KUQU;3_PD\_[(U^1W M_BS?\]O_`%BCZVH?<$=3?U1O M_P`*+.V,-UG_`"K.[<'7U-+#F>X]S]6]5[4@J7YK?+65`3';)+*_R'AE!_P`;=1U&?NY?QV7(]S$Q M'B7#Q1+\SK#G_C",>M*W^1]UED.U/YIOQ!Q%%3O-!M?L&M[-RDX\@BH,QI-D<)3TZ7.EIIT0A@VDY+>Z%\EAR)N,C',D(B'S,K*G^!B?L M!ZQR]M;)[[G?;XU&$E,A^0C5G_PJ!]I'7U&O>#'6;/7Q[_D?_P!E#]\_^)G[ M1_\`>XSGOHGLW_)'M/\`GFB_XXO7/[>/^2M=?\],G_'VZ^H;_*C_`.W:OP:_ M\5DZE_\`>3Q_O!KGW_E==T_Y[I?^/GK-;D7_`)4[;/\`GBB_XZ.K`_81Z%?6 MI5_PK1_[)X^)/_B9][_^\/![R`^[_P#\EC9/^/\`4#^_'_))L/\`GI?_ M`(YU65_PE*_[>'=R_P#BF'8?_O\`#XZ^QO[]_P#*GVW_`$LH_P#JQ<=`OV,_ MY6VX_P"E=)_U>M^OH%>\2.LK.OC$>^DO7.WK[!_QO_[)WZ%_\0OU;_[P^"]\ M[=Z_Y+%W_P`],O\`Q]NN@.S_`/))M?\`GFB_XXO0T>RSHQZ][]U[HA_\SCY+ M1_$;X'?)GO*#(?PW<>W^MZ*K.HJY(V4\P\UV.UD:H7G#2>GAQ]\E?M52!\R/LZ"_.F\C8.5[W< MP:3)"53U\1^Q*?8S`GY`]?,!^)/>V.^,'R4Z8^0V2Z^H>TDZ:WSB^P<=L;)9 MN7;M%EMQ;<\M?M6JES,&,S,U$<#N:.DR*%::0N]($].K4N;;=GB$_T\HD"$Z067*FM#32U&X> M76S]_P!!<'8G_>$.R_\`T>><_P#M9>X._P"!]L_^CI+_`,X%_P"MO4U?Z_5W M_P!&V/\`YS-_UKZU?_EIWKC_`)._)3N?Y#8[8%%U>OY9JNO8M31LC510ERNMIQY?VI]CV6VV=YC/]-$( MPY722JX7%6II6B\?+RX=0KOVYIO6\7.[)$(/J)3(4!U`,V6S05JU6X>?Y];S M?_"7WY-KVU\%MS=`Y:O6?<_Q=[&R&*H:5YQ-4KUKVG/D]\;3JIB]IP!NX;EH MXU.I(Z>CB56L`B8N>^6Q_N_FE-VC%(+Z$$GR\2*B./\`>/#/VD_:OK M^6'VJ0UGLIB`/^%RU=3_`+WX@^P#[!8]_.9_[=X?\\,__5I^L.N6_P#E8K#_`)[8/^KJ]?7<]\]NL^>O>_=>Z][]U[KY MX/\`PJ,_[>58+_Q63JW_`-ZSLSWF![%_\J4__/=+_P`/SS_P#%,/E'_P"^/WS[$O)G_*X;3_TLK7_J M^G0=YP_Y5+=/^E=<_P#5E^OE=_'6..;Y!=%0S1I+%+W)UC'+%(BR1R1R;VP: MO'(C`JZ.I(((((/O.[>"1M%T1Q^FE_XXW6#^T`'=K4'A]1'_`,?7KZ[_`/HW MZ[_YX+9?_H+8/_ZA]\]?K;S_`'[+_O3?Y^L^?H[3_?4?^\K_`)ND;V-USUZG M7N^W38FS4=-F[H967:^$5E9<)7%65A0@A@1<$?3VIL[R\^LB_5D_M%_$W\0^ M?2>[M+06DOZ4?]FWX1Z'Y=?'N]]$^N?W7V0^M_\`F7>PO_#+VM_[HZ'WSCO? M]S)?^:K?\>/70FS_`-Q(O^::_P#'1TM/:;I3UII?\*UNG,E-C/AW\@:&CE?$ M8^N[+ZY,(U36S).!\D)#G\HV=ORZCSVGW6/:^=;<3'3%^?_,W_*R; MA_SW3_\`5U^L\.6_^5=L/^>*#_JTO6A3_P`*8_\`MZ/NO_Q#'3__`+IZ_P!Y M7>R?_*BQ_P#/3-_A'6+GO+_RNTG_`#S1?X#U>C_PD\_[(U^1W_BS_O_*R6?\`SP_]99.I.]BO^5=O/^>W_K%'U2!_PHR^!47Q2^8S=X;#PS4/ M3GRP;.;\IDI8=..VWV_1U<,G:6W8Q&K)24^:JLG39^E#E`[Y.JA@0149M)_L MWS6=_P"7/W7=M7<=OTQFO%H2/TF^>D`QG_2J2:MU&GN[RL-BYA_>=JM-OOZN M*<%E!_57Y5)#C_3,!A>KU/\`A,G\_3W=\>\]\+^PLU+5]F?&VD&8ZWEKYUDJ M<_T-E:^&EI<=`[R2553+UAN>M^P2Q<$0(A?3%GO=RE^[-W3F6S6EE M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T`]?TV.GY*R` M<.MHSW!G4V=?'?[XZYK>GN\.Y.I7725.S-V9;;LU. MWGFJ9CXGQQ%VDD8@7+-]3T6VJ\7<=KMMP0U2>".0'U#H&^7KZ=<^]TLVV_<[ MBP<4>">2,CTT,5_R=?52_ES[\H.S/@-\,]ZXZ=:A,O\`&7I:*N99S5>'.8C8 M&"PFXZ)ZEO7/+CMP8VIIW=@&9XB2`;@8&\XVKV7-FY6SBA6^FIY=ID9E-/FI M!_/K.+E&Z2]Y6VZY0U#64-?/N"*K#\F!'1SO8;Z$76J'_P`*R^PJ+&_%CXN= M4R5<29+>G?\`FNPJ2@(3S5-%UCUUF]MY"KC)0R"*BG[S!;U"W!-B)\]@ M+-GWV^OP.R*T6,GT,LBL!^?A']G4%^^]VJ;'8V)/?)=F0#Y1QLI/Y>*/V]5% M_P#"7#K[)[H_F+;GWI#'*F'ZQ^.V_P#+Y&K%Q3FOW+N'9>T<5BW80RWJ*R#+ M5=1&I,8*44AU>G0\A>^EXD')R6Q_M)[R,`?)5=R?RH!Y\1]H`/LE://S<]R/ M[.&TYX88 MP6(!>66154?5F(`Y/O(#W=!/MYN-/^$?]I,/4#^U!`Y_V^O_``__`+1INOIN M^\(^LSNJCOY[U33TO\IGYCRU4\--$VTM@4RR3RI"C5%9W)UQ1T<"O(RJ9JJK MG2*-/U/(ZJH+$#W(/M4I;G_;0H)/B2']D,A/[!D]`+W/(7D3<"Q`'AI_.6,# M]IQUI,?\)[%9OYOOQ'*J2$'?C.0"0JGXQ]T(&8C](UL!<_D@>\FO=[_IW>X? M\V/^TF'K&[VG_P"5_L/^;_\`VC3=?0\^;'_9&?RW_P#%8^^O_?5[K]X@*?_JTW7RB_CA_V4/T-_XF?J[_`-[C!^\] M]Y_Y(]W_`,\TO_'&ZP8V?_DK6O\`STQ_\?7KZ7/RU_DM_P`OKYH]EY7N7N+J M;+TW:FX(,;!N3>VP][[FV=7[D7$45+C,=/G,70UTNVZ_(4^,HXJ;[MJ$5;P1 MHCR,$33A3R_[ELR-^]N>5 M.8[QMQW"!A?.!J='9"U``-0!TDT`%:5H!G`Z"'JO_A//_*NZMW!3[E?H?+]D MU]%/'44%)VIV'O#=6WZ:6,C_`($;6@R>)VWG('`(:')4M;";_H^EC"_]W^?+ M^$PB[6!"*$Q1HC'_`&U"R_:I4](+'VFY'L91-]*TS`X$LCLH_P!K4*WV,".K MGL!@,#M3"8G;.U\)B-M[;P&/I,1@MOX#&T>'PF%Q5!"E-0XS$XK'0T]!CL?1 M4\:QQ0PQI'&BA5```]QM+-+<2M/.S/,Y)9F)+,3DDDY))XDY/4B11101+#`J MI"@`55`"@#@`!@`>0'3O[;Z_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>ZU:?^%-_P%WMW_P!+]=?+7J;;]7N3=/QOH-R8;M'`XBCJ M*[-9#I_.ST>7&YZ2FIHIIZFGZUS='45%7&B_MX[*554Y$=*WN=?9'FRVVGE3$Q-%$RU&DD\/$4@#^DJJ,MU"/O/RM<[KMT._6"%Y[,,)%`J3$U M#J`'^^R"3_19F.%ZUP/Y*?\`-+H_Y:'>V[Y^P\)F]S=`=V8K!X/L^AVS%!5; MEVYEMKU.2GV=OO!8^LK*&DRK809VOIJVC,T+ST=:\D;--!%%),WN9R(W.VU1 MBS94W:U9FB+85@P&M&(!(U:5*FAH5H<$D1![<<[KR;NS6UJ'-TU4A!'C:#4Y_3J!!.,$OMCSY#*86VVY/(\L0E7<80I%:,'5OS4J#7\NM:'^?#_.^Z;^6O5*?#_XBU^5W=UIF-Q83 M0PV:VQB]TIM3(19C;FR=GX/<%)C,]5XJ'@ITI5E MC9Y?JC+#$"K%=8HSNRDJ#I)554G#'50T'4->Z'N5 MMV_6/]7]@+26;.K2RD%0VDU5$5@&(U`,S$#*C345/7+_`(2^_`K=V[^],S\] M=[[?JL;UEU/A=T;(Z;R5?"U/_?#M+=6/EVUNK,X(.=5;@MD;*R.0H*J?QB"3 M(Y:..&5I:*KCB][YRO M*UQ<;FW--RA%E`K)"3^.5AI8KZJB%E)X:F`!JK`;V'O%CK)WKY>7\]7_`+>Q M?,G_`,/39?\`[Z7K[WG+[6?\J!MO_-)_^KLG6%/N=_RO>X_\U$_ZM1]?1Q^$ M_P#V1G\2/_%8^A?_`'U>U/>&W,W_`"LFX?\`/=/_`-77ZR\Y;_Y5VP_YXH/^ MK2]4[_\`"DKX4_[,A\(I.^-J8EJSL[XDU>1W^&I::*2LR?4&7BI*7M;'226C MD6GV]24-'N)G9V6&FP]2JH6FN)%]E^9OW+S/^ZKAJ6.X`1Y.!,*F(_[8DQ_, MNN<=1][P\M_OCEK]Z0+6]L"9,<3$:"4?[4`2?((V,]?/K7LW>`ZMFZ;?)M-L M!]_TW9M-AI@[KC=X1;=J]JUN3QQ$BQP-FL+-3Q5ET8R_P^EL5$9#Y<_0VWUP MW(+2[\$Q$^J:@P!_TK5(]-3>O6*7UMQ]"=N+5M?%$E/1])4D?:*`^NE?3K"_W,VO\`YI3_`/'HNLA_87_<3\D_N]?\M? M_J%_[6>L=O?S_ED_]17_`&K]%D_X2>?]EF?(W_Q6.?\`]^IUY[._?W_E6[/_ M`)[O^L4G1+[%?\K%>?\`/%_UECZWU_>*/64?0+_)#_LG?OK_`,0OVE_[P^=] MF>R_\EBT_P">F+_CZ]%V\?\`))NO^>:7_CC=?'P]]$NN?W7T/?\`H*-_EJ_\ MZ'Y.?^BNVE_]L[WA_P#ZQ?.O\=C_`,Y7_P"M766G^O9R=_#>_P#.)?\`K9U[ M_H*-_EJ_\Z'Y.?\`HKMI?_;.]^_UB^=?X['_`)RO_P!:NO?Z]G)W\-[_`,XE M_P"MG5HWP+_F/?&S^8WL[?&\?CO6;R2+KG/X[;^[\#OW;<>V]P8J?-4517X2 MN\%'D\WC*K&Y>&BJ1#)#5NX>FD61$(74!>:^3-ZY-N8K;>!'69"R-&VI3I-& M&0I!%16H\Q2O0UY6YOV?F^WEN-H,E(7"NKKI85%0<$@@T-*'R-:=:=/_``JU M_P"WAW37_BF'7G_O\/D5[R,]A/\`E3[G_I92?]6+?K'SWS_Y6VW_`.E='_U> MN.C)?\)U_P"8O\+/AM\8>[]B_)CO?`]4[KW1WS+NS`X?+;?WMEYLCMYNOMF8 M<9..?;&V,Y211')8R>+1)(DEXR=.D@DE]XN3N9>9-\M;K9+1[BWCM-#$,@HW MB.:=S*>!!].CGVCYNYV6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\` MRGMBXNJK*3Y(5_8.4@I#5TVVNO\`J?MG)93)"U0$IJ7)YO9FWMGT]7))3Z1' M5Y2F*ZT9M*-K]Q=:>T'/]U(%:R$*$T+22Q`#[0KL]/L4_MZDR[]V>1+5"RWA ME<"NF.*4D_82BI7[6'[.M+?^;O\`S9=Z?S.NT-LOC]MU_6W075BY2'K'KRNK MX:W,UV2R\D:97?F^)Z(G'R[IRE%304\5+`TU+BZ6,Q0R2O+4U$^2OMYR!;NV*O:V_.XMIT^TNE]IYRD2G MS>#ZFR-3C=P9;>^3HJA6J\37[_KL?1I012+!4QXND:5@T5>H$,^]/.]MN]Q' MRSM3B2TMI-UI0"H0'@1&"=1R-1IQ3J7_`&^B>S?\D> MT_YYHO\`CB]<_MX_Y*UU_P`],G_'VZ^H;_*C_P"W:OP:_P#%9.I?_>3Q_O!K MGW_E==T_Y[I?^/GK-;D7_E3ML_YXHO\`CHZL#]A'H5]:E7_"M'_LGCXD_P#B M9][_`/O#P>\@/N__`/)8W#_GF3_C_4#^_'_))L/^>E_^.=5E?\)2O^WAWM_GJ#_A3)_+HV-U-U?LG-8/Y)/F-G]=[)VMEFH>L]J3T3 M9/;^VL9B:]J2>3LF"2:E-52.8W9$+)8E0>/>)>X^R?.-UN$]U$UEX7E&VL(+:1;SQ(X44TC6E54`T_4X5'0B?]!1O\M7_`)T/ MR<_]%=M+_P"V=[1_ZQ?.O\=C_P`Y7_ZU=+/]>SD[^&]_YQ+_`-;.K'_@'_-* M^+7\R)>RHOCS4;_I,KU0VVY-V8+L3:D&V!"8[C5H:-]0JE-0-0I!HP/"AK@U!H M+^5>=]DYP\8;291)!IU+(NDT:M"*%@1VD<:BF1D5H:_X5@_)@8CKOXW?$7#5 MBBLWGN++=[;[IXRR3PX':-/6[,V!32M^F:@SF;SF;F9/[,V'B;^GN5O8+9/$ MO+WF&0=L2""/_3/1Y#]JJJ#['/47^^N\^':6>P1GNDZ&[ZZ.[[^0_R8Z3V!W!A\]V%A.L^K<=V3M;&[CHL/%L?#29K>V?P MM/E*>:-5SE?O*AHFF4?YS$RH#PWLP]Z><]UVK=+39]DNIK>1(6DE,;%2=9TH MI(_A",U/Z8/1?[.\G[7NFV76[;S;17$;2B.(2*&`T"KL*_Q%U%?Z)'6RW_PU M'_+5_P"\&OC)_P"BEVG_`/6_W"O]?>=?^CI??\Y7_P`_4R?U%Y._Z-EE_P`X ME_S=:Y?_``I#_EI=`=*_&;J#Y%?&/HSKKJ"GV%V95;*[4I.M=JX_;$.9V]V- MC(?[M;@ST6,@@IJF+;>Y]L1T$+M^XLF=L+J3IF3V8YUW;<][N-GWRZFN#+`' MB,CEJ-&>Y5KD:E8L?+LZB'W@Y-VK;=FM]WV6UAMQ%,4E$:A:K(.UFICM9=(_ MT_59G_":[Y.CHK^8EB.L,SD!2;/^4&RLWU95I4.R44.^,0AWKUYD'"$,U?4U M^%J\+2@AE\F<((%]:#;WIV/]Z\GM?1BMS8RK*/70>R0?8`P<_P"DZ!OL[O7[ MLYM6RD-+>]C,1]-8[XS]I(*#_3];F?\`.9_[=VW_*] M;9_STC_`>LA_<3_E2=R_YYC_`(1U\R#X\]@X;J7O[HWM7<=-DZW;W6?H\)#2U.9J\-LS>F$W'E*;$4]?6XVAGR<]#C72G2:HIXFE*AY$4EAF[O%G+ MN&T75A"5$T]M+&I:H4,Z,H)H":5.:`FGD>L,=INX[#=;:^F#&*&XCD8"E2$< M,0*D"M!BI`KYCK>I_P"@K7^7C_SYKYG_`/HO.C__`+HKWBS_`*PG.'_*3MO_ M`#DG_P"V?K)O_7SY2_Y1]Q_YQP_]M'2_ZJ_X4[?R]NUNR]A]9TVP/E5LVKW_ M`+LP>SZ'=&\>O.L1M;#9#<.0@Q>/J\\VTNZ-V[CCQHK:F-9'I,;62H&U>,J" M0DO_`&/YOL+*6],UA(L,;.52274P45(77"BUH/-@/GTJL?>CE.^O(K(17T;2 MR*@9XX](+&@+:9F:E3Y*3\NMB[W#G4N]?/!_X5&?]O*L%_XK)U;_`.]9V9[S M`]B_^5*?_GNE_P".1=8E^]G_`"N*_P#/%%_QZ3JYW_A)Y_V1K\CO_%FYO_?5 M]?>XV]_?^5DL_P#GA_ZRR=2+[%?\J[>?\]O_`%BCZVH?<$=3?T3#^8__`-N\ M?GG_`.*8?*/_`-\?OGV)>3/^5PVG_I96O_5].@[SA_RJ6Z?]*ZY_ZLOU\K[X MX?\`90_0W_B9^KO_`'N,'[SNWG_DCW?_`#S2_P#'&ZP@V?\`Y*UK_P`],?\` MQ]>OL(>^=G70'I%]D?\`,N]^_P#AE[I_]T==[4V7^YD7_-5?^/#I->?[B2_\ MTV_XZ>OC>>^CG7/;K[(?6_\`S+O87_AE[6_]T=#[YQWO^YDO_-5O^/'KH39_ M[B1?\TU_XZ.EI[3=*>B4?S#?AIMCY[?$KM3XV[@K:?"9/=.-I\OL#==1#)/' ML[LC;"0J5;WG9MNY;;O\`MJ7]@Z3[?.F#Q!!P58'@1E65A4&H M(ZPBW';MQV+<7L;Y'@OX'R.!!&0RD<0<%6!H10@];JW\NK_A3'\?MX]=[7Z[ M^>U=E^I>W=OX^EPU=W%C-K9K<_6G8WVJ)2T>>RV/VA0YG2.DVUM_L3=F8D)562+^"[:V;E.-_C5%!^T``]86W+K)<22)\+.Q'V$D]?6W^$_\`V1G\2/\`Q6/H7_WU>U/? M/WF;_E9-P_Y[I_\`JZ_6>7+?_*NV'_/%!_U:7K0I_P"%,?\`V]'W7_XACI__ M`-T]?[RN]D_^5%C_`.>F;_".L7/>7_E=I/\`GFB_P'J]'_A)Y_V1K\CO_%FY MO_?5]?>XL]_?^5DL_P#GA_ZRR=2=[%?\J[>?\]O_`%BCZN!_FN?!R@_F`?"W MLOI&E@HE[)Q:0]B=*9>L\:+BNT]I4]9+AJ5JF4A*.BW=C*NMP57,VH04N4DE M"EXTM'?(/-#\I<3TU&GF4(#@>94#@>A_SURRG-?+DVVJ!] M8OZD)/E*M:#Y!P2A/D&)\NOFS?#+Y.]B_`?Y;]9=]X+'Y.GW!U-O26AWSLFJ M>;$5.XMJS23[?[&Z_P`Q#41D4=5E,)-54R&HAD^QR"Q5'C,L"6S0YDV.SYLY M>GVF4J8;B*J.,A6^*.0>H#4.#W+45H>L/.7=ZN^5M^AW2(,)8)*.AP67X9(S MZ$BHR.UJ&E1U]7_J_LG9W*0,C`,I`P&OK*YVV]EV^\4I=0R,CCT9201^T8/GQZSI MLKRWW"SBO[1@]K-&KH?56`(_D>'EPZT+/^%)_P#+UW9TA\H,E\R]C;-I*B:@V%W72T%/CL[09R2.*2/'TG8T%"F8HIYI?\JR4F1B546& M(/E;[+ZYWE5TM/-+MWP[EKZW)8W)U%Z%UK9J:>2F\--]P2 M^[?MIN6[7YYFY>C,T[JJSQ+\9*C2LB`GN[0JLH[NT,`U6H<^U7N-MVU6`Y;W M^00P(S&&4_``QU-&Y'P]Q+*Q[R]-3J6E;;NU-A9;V5)&/\`I50LS?[4 M'KYZO\X?^9#/_,F^4K]@;;QN5V[TEUK@WV%TMMS-"*+,R8/[Z3(9S>FX:6": MHIJ/<6]_JX0R;;"NB%3QTUJSL/)G.:>2A1D@D[?7_``G3 M_E[[F^'?Q6W!W%VS@I\!W-\I*K;NZ*C;V2I1!F-F=5;>I<@>O,%DHI&EFH,U MG7SM;F*Z&\4B15='3U$25%(X7'GWBYO@YCWY-NV]P^VV`9=0.'E8CQ&'JJZ5 M13G(8@T8=3][1\IS:[/=IR1:(Y63SI'(I1C09.D-KH,DKT+N>-BDY MCY7N]J@`-TR!H_\`3QL'45X#45T5/`-U\T'XG=Z;O^#7S#ZC[OKMJ9)=S]`] MJP5.\-AYB"?!YR6DQ=95[;[#V560UT*5&"S]3@ZG(8^\\1:BJV#21-H9#FOO M^U6_-/+EQM:R+X%W;T20=RU(#1N*?$H8*V#D<#FO6&VQ;G<A[6H"5D0U^%BNI=)_P`US^7=WSL/&[^VC\NNC-O4M9BERN2V MOV=V1M'J_?FUA'%&V0I=S[/WOF<-E\><5.YAEJ8TFQ\K*7IZF:(I(V%&Y\@\ MX;5=M:7&WW3L&H&BC>6-O0JZ`@UX@88>:@XZS)VWGKE+=+5;JWO[9%*U*R2) M&Z^H9'((IP)RI\B1GK7=_P"%#'\WKXW=M?'6?X6?%_LK`=RY3L#=FU\QW!O? M8]8,UU[@MH;'S%)NS$;:Q>ZZ4C#;ISV;UM^\#F7?('MHX8V$*.-,C.X*%BARJJA848`DL*"@/42>[//^SW^T'ES9 M)DN'ED4RNAK&J(0P4,,,S.%/:2`%-34CHM7_``EI^'N\-W_([?GS/SF%JZ+K M+J':&X>M]E9NH@>*FW%VKO:GQU/F*;$3LP6KBVEL.HJ17V4B.3,4@O^ MO,5M;[-%RU$P-]<2+(Z^:Q)6A/IKDII^2-T3>R/+]Q<;Q+S%*I%E;QM&A_BE M>E0/72E=7^G7K*?_JTW7RB_CA_V4/T-_XF?J[_`-[C!^\]]Y_Y(]W_`,\TO_'& MZP8V?_DK6O\`STQ_\?7K["'OG9UT!Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZXLJNK(ZJZ.I5E8!E96%F5E M-P5(-B#[]PZ]QP>M?WY=_P#";_X"_)?<>6WYL"#=_P`7][YFHGKLFG4+8>3K M?)9&JE>6>NJ.L\[05.-P[%F&F#!56%HQ8DPEF+&6^7O>;FS9(5M+LQWUJHH/ M&KX@`\O$4@G[7#GY]13O_M!RMO,S75J)+*Y8U/A4\,D^?AL"!]B%!\NJSJG_ M`(2)T[5$[4?\P*:"D::5J6"I^*Z551#3EV,$4]5%\C:.*IFCBL'D6&)78$A% M!T@;+]X0T&K:`6IFEU3^7TYI^T_;T#3[!BIT[J0M>_\`L[Y,5^+JEJ8=KY3['K/K6N:-F>#^,[>VO49'=^1\$@1O M%_>*.DFTLDT$L;E/8:WKWSYGW")H-KA@LD84U"LL@^QFH@^WPZCR(.>A'L_L MGRW82B;P&'Q\*T]#BL-AL7!2X_&X^C@0)'##&D:*+`#W#-Q<3W< M[W-T[R7#L69F)9F)XDDU))\R>I@@@@M85M[9%CMT4!54!54#@`!0`#T'2@]L M].]4!_,S_A/!\4?FC\D.P/DOO#MOOC8^Z^S9\%6[IP&S8J65"FFJJ%J-2$BH`\SG]G M5YO7VQ]O]8[!V1UKM.&HIMK=>[0VUL?;5/5U,E;5P;?VGAJ+`X:&JK)KS5=1 M%CL?&KROZI&!8\GW%MY=37UW+>W!!GFD9V(%!J62<=29:6T5E:Q6<`( M@BC5%J:G2H"BI\\#CT^9O"XC*KQV5Q&5I) M:')8VOI)E>&JHJZCG>*6-P5>-R""#[:BEDAD6:%BLJ,&4C!!!J"#Y$'(Z=EC MCFC:&50T3J0P.0010@CS!&#UK';G_P"$IOP_7-$<*Q MS6ME)*``6(D!8^I`DH"?.@`KP`&.H7F]C>69)6>*YO(XR:A08R%'H"4J0/*I M)IQ).>K7/Y;?\K[H_P#ED;-[)VKT]NSL7?%7VMN+"9_=>X>QLA@JBMT[:Q]; MC\#BL71;N^]W;RI.[?D=M:BW7N?,[D7:^(R/6]3C<$ MN:R,^2DP^*J\GL"KKVQ]"]2T5.:AYIEB50[R,"S3=:>^W,UM:1VS6ME(T:!= M1$@+:12I`D`J:5-*"O`#J&+KV0Y;N;J2X6YO$61RVD&.BU-:`E":#@*U-.-> MMC'J?K3:_2_5G6O3NR(:RGV7U/L#9O6FT(,A5&NKX-K[$V[CMKX"&NK2D9K* MR/$XJ%992J^1P6L+V]PYN%[/N5_/N-U0W-Q,\CT%!J=BS4'D*DT'4NV-G!MU MC#M]M46T$21I4U.E%"K4^9H!GI?^TG2KJL7^95_*LZ)_F>8/J?&]P[N['V-E M.FLGN^MVAG^NJ[`05+46^Z;;L&Y\3E:+6X?;HX98[E4#K(&I5"VD@JRD$:V'F#7Y#H%\X\C[7SI%`FX23 M1/;LY1HRM:.%U`AE8$'2I\B*?/I"_P`MO^3=\=?Y9N[^Q]_]5[V[1["WAV1M MO&[/J\KV-6[9:/![:H6XF M0(3(5[5!J0`JKQ-*DUX"E,UMT]Q[T/ND[N_:^+WOM+=&R\W]P<+N_;N;VOEQ M23"GJSB\_C:G%5_VLY2005'VE6^A]+:6L;&UO;UO/):W$=S%3Q8W5A7A52"* M_F.F;B!+F![:2OAR(5-.-&!!I^1ZUA)?^$GOPP,DAA^1?R>CA+N8DEJNJ99$ MC+'0DDJ]7M/MB_Z MU]8_^@3SX:_]Y'?)O_J=U7_]K[WO_7]YD_Y0['_JK_ULZ]_K%9/^4.Q_ZJ_P#6SKW^L5R[ M_P`IE[_U2_ZU]6Y?RV/Y772G\L?:G:&VNH=Z=D[ZF[:S^WLYN;+]C5FW9IX% MVK09*@PN/Q-)MO;^`I*:GA&9JI)7D$TLKR@:@J*/';Y)I3.ZLQD*_A!``"JH'$UXDUZ M!O\`F/?R4/CE_,K[7V1W-VCV)VYU]O39G7L/6(DZ]K]K?PS,[7Q^Y,_NK#)6 MT&YMM9T4]?C,MNS)GS0/'YHZA5<'Q(?9CR9[F;SR582[;8PV\UM+-XOZ@:H8 MJJFA5EP0BX/"F.)Z+N;_`&WVCG*^BW&]FN(KF.'P_P!,K0J&9A4,K9!9LCC7 M/#JO'_H$\^&O_>1WR;_ZG=5__:^]C#_7]YD_Y0['_JK_`-;.@G_K%9/^4.Q_ZJ_P#6SKW^ ML5R[_P`IE[_U2_ZU]6$_%#^0I_+A^)>X:#>N$ZMS7<^_,//#4X3=_P`@\W0= M@S86J@D,T5;C=IX_![8ZXBR<$XCDAK&PCUE+)$K02Q-J+!#?_=?G/F"$VTLZ MVUJPHR6ZF/4/0N6:2GJ-=#7(/0KV+VNY0V&87,4#7-TIJKSD2:3ZA0JQU]#H MJ*8(ZN8]QOU(G7O?NO=:TO;G_"7KX5=I]J;_`.S(>Y?D7LV+?^\,[O.IVGA, MKU[78G!UFY,E/E\GCL-6YO8E?EOX9'7U/6PATSU-L[H;J3K/I3KVEJJ+8W4^Q=K=>;3IZZI%;D%P M&T<-1X/&R9.M$T72SJO+^ M8S_+:Z4_F6]7;/ZS[BW#OK9YV#O`[SVKNKKZOQ-+F:&LJ,94X?*8ZJI<_B_YW? M(9'+[2QQ,\\DOBCIRL:KY')-^<_>=;"+;;Z&WAM8IO%_3#5+!645+,V`' M;`I4G/`=%7*'MQL_)M])N-C-<2W,D7A_J%:!2RL:!57)*KDUI3'$]7(^XXZD M+K5NRW_"47X3UN5R=9C.^_DQA<;5Y"MJJA)(%8S0>0J8ZFG"IZ;_`/H$\^&O_>1WR;_ZG=5__:^]W_U_>9/^4.Q_ MZJ_];.J_ZQ7+O_*9>_\`5+_K7U[_`*!//AK_`-Y'?)O_`*G=5_\`VOO?O]?W MF3_E#L?^JO\`ULZ]_K%_]4O^M?5H_P#+4_E&]$?RQ:WMG+=2=@=J M;_R_;]+M+'9ZJ[&K-JR4V,QVS9<[4XV##4>V=LX#1/55.XIVJ)9Y)]2I$L:Q MZ7,@%YU]P=UYX6WCW"&"&.W+E1&&R7T@U+,W`**`4\ZUQ0;]^R^T.Z]A;RQ6Q<7 MU_44NQLQMFIP%?AL'D\OE,5-'CMV[;W`^(JH9L[4B5:.2&FF+"0Q"9I9)5W) M_NCO7)NV-M5E!:RVS2F2KA@P+``Y1EJ.T4J"1PK2@"'FWVSV?F_%`>-*U)L9^(WQ6ZJ^%7Q]Z_P#C=TS3Y=-B=?4N46CK M]QU=+D=SY[*9[-9#<.=W!N3)45!C*:NR^5R^4FD8QT\,,,>B&&..&*.-0=S# MOU_S-N\V];D5^KF(J%!"J%4*JJ"20``.)))J2223T+]@V.QYK[EW=H=YVTJ+R!B5U"JFH*LK`$$JRDJ:$&AP0<]%6][/9;_`+7-M&X` MFTG6C4-&%"&5E)!`96`(J"*C((QU27\:_P#A-1\/_C=WWU+W[C>X_D'O;-]. M[YP'8NV]N;ARVR,;@:S=.U*Z+,;:GR\VVMG8G,U%#C,Y2P53TT=3%'5>$0S: MX'DC>3=Z]ZN8MZVFXVE[:SBBN8FC9E#E@KBC4U.14J2*T-*U%"`1&^S>SG+^ MS[I!NJ7%W)+;RK(JL4"EE-5KI0&@8`TJ*TH<$CJ\GY%=$;(^3W1?:GQ][';+ MQ;)[: MOIKB,HQ4T8`^8-"*@Y%0149!&.M<;_H$\^&O_>1WR;_ZG=5__:^]S+_K^\R? M\H=C_P!5?^MG40_ZQ7+O_*9>_P#5+_K7U[_H$\^&O_>1WR;_`.IW5?\`]K[W M[_7]YD_Y0['_`*J_];.O?ZQ7+O\`RF7O_5+_`*U]+KK#_A+C\,^M>R-A=B'O M+Y';E;8>\-N;QAV_DLAUS18W,U.VLO29FEQN2JL7L2FR4./JZFB1)S3RPSF( ML(Y(V(=4M][Z+&R:@)"0&!!(!D(J`<5!%>(/#I39>R?+MG>1 M7?U-X_A2*^DF,`Z2"`2$!H:9H0:<".MF?W"74S=4K_S$OY'/QL_F.=T8#O;L MGLCN'KS>>'V%B^O*N'KZOVFV&S.)PF7S>7Q-;4T>Z-L9Z:DR=.^X*B%V@ECA MEB6.\8=7>22^3_=#>N3=M?:K*&VFMFE,@\0/J!8*"`59:CM!R*@US3`CGFWV MTV?F_<4W2\FN(;A8A&?#*T(4L02&5J'N(P:$4Q7)-5_+K_EU].?RU^G-R=/= M/;DWYO"DWAORO["W+N7L*OP]7F*S,5>'PVWZ:CHZ;;^&P6)Q^*Q^)P4`1!`\ MSS/*[RLK1QQ$/./..Y^W[>\LBR2F1FD())("T&D*``%'E6M23P`/]["70JZ#[MKK/;'=/579 MG3F]DK9=F=L]?;SZSW=%C:D461DVQOS;F2VMGTH*QHIUI*U\5E91%*4<1R6; M2;6]J]OO9]LOX-RM:?4V\R2)45&J-@RU'F*@5'22_LH=QL9MON:_3SQ/&]#0 MZ74JU#Y&A-#UKO=7?\)<_A=UIV;L+L<]V_)#=";"WEM[>=/MK*Y3KJBQV:J- MM9:ES-#B\M78C8-'E$QM554<:5)I9*>H>$N(I87*R),-][Y\RWMC+9_2V4?B MQLFH"0E=0()`,A%0#BH(KQ!&.HELO9/ERSO8KSZF\?PI%?23&`=)!`)"`T)& M:4-.!''K9B]PGU,O4+)8ZCR^.K\3D8?N,?E**JQU=3^26+ST=;!)35,/E@>* M:+RP2LNI&5EO<$'GW9':-Q(AHZD$?:,CJKHLB&-\HP(/V'CUK!?]`H_P>_CO MWW^G;Y/?P+^+_=_P#^,=8^7^$_>>;^$?Q?\`T;^?7]G^S]SX]=_7IOQ[G'_7 M[YH\+1]+8^+IIJI+QIQIXGKFGY=0K_K&+J^JO?"U5TUCX5X5\/TQ7\^MG MW&XZCQ&.H,3CH?M\?BZ*EQU#3^267P4=%!'34T/EG>6:7Q01*NIV9FM1II(=O[QQ9BR*8V2H8RR8ZJ^ZQD MTMGEIG95($W+?.','*:81 M%O$`=U':X[9$_P!*XS3STFJDY(/6N#VC_P`))=FUF3J*OI;YG[GV]AVF;[3` M=H]1XK>63CIV<:?N-W;3WGL2EFFACN#IPD:RDW_;`L9FL?O`W*H%W/;4>2F6 MBE*"O^D=)#_QO'SZB"]]AK=G+;=N+I'7"R1!S_O:N@_XQGY=`MB/^$D?:\U7 M.F>^:?7F-H5JXTIJC$=.[DS=7+0&1A+4ST59OG;\-/5I"%98%GE1F)4RJ!J) ME)]X*P"@Q;9,STR#,JBOI4(U1\Z#[.BZ/V&OBQ\7Z^RDR$/,% MV4!(X-R4X52P>\(_#B*,_:%+/\`LD'SKULR[=V]@]I;?P6U-L8F@P.VML8?&;>V]@\7 M31T>,PV#PM%!C<3B<=20JL5+08Z@IHX88U`5(T"@6'N$III;B9[B=B\SL69B M:DLQJ23YDDU)ZF:&**")8(5"PHH55&`%`H`!Y`#`ZI:_F"?R(_C+_,,[WC^0 MG879O70AY2Y3V_ MD_;6VW;VDD5Y3(S.06+$!?P@``!0`*<:GSZ/I["G0IZU\/EK_P`)POA?\K.^ M=^_(";?W<_4NXNS&2FDJ<]N:BH]Q[/R]?C:W<59(U M361K4M"]6\DJ*AD8>Y=Y?]Y>9=AVJ+:!%;7$,"A4:0/K"#"J2K@$*,#%:4&: M=11OWM!R[OFZ2[J9;F":9M3K&4TES\3`,A(+')S2M3BO5NOPZ^+.QOA5\;^L M_C+UQF]V;CV?UC0YFEQF;WMDHF M@A@IX=**O!)CWF/?;KF;>9][O5C2YG()5!11I54%*DG@HJ222<]#WE[8[;ES M9X=FLVD>WA!`+FK'4Q8UH`.+&@```QT-'877>Q.V=E;CZX[.VAMW?NPMWXV3 M$;GVANS$T>7# M_'W)9&N;201%%!6]OXJG3R"X\AD;0>=#_3V(9/O!P!/TMJQB*66W."&6*NMU/$/(>ZAX$($!&&!'4@\OT(*M+32I M'`K&,5\P6+D'*D'J]KW%?4G]>]^Z]U3O\^_Y(/PJ^?N=KNQ]V87<'4?=U="B M5_;74]3CL7D-S24\2PT3[]VSE*#([:W8]/$@0U?AI,M)$J1&M\<<:+(O*7N? MS-RE$+.W9+C:P<12@D+Z^&P(9*^E2EQFS6THEW:[FNE!KH51"I^3'4[T_TK*?F.MG;K M'J_KOI?8>V>K^I]E[=Z]Z]V;C8\3MG:.U<93XG"XBB1GE=:>DID4/4551*\U M1/(7GJJB1YIG>5W=H0OKZ\W.[>^W"5YKR1JL[&K$_:?08`X`````=33965IM MUJEE81I%:1BBHHH`/L^?$GB34FI/4OL38N`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` end